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I. INTRODUCTION
Whether patients who obtain their health coverage through private
employment ought to be able to sue managed care plans for injuries resulting
from coverage denials has been a significant health policy issue for years. The
debate became more intense as recent judgments against major managed care
plans highlighted the inequity caused by the preemption provisions in federal
employment law.' A Kentucky jury awarded $13 million to Karen Johnson after
finding that Humana Health Plan, Inc. wrongfully denied insurance coverage for
a hysterectomy recommended by her doctor.2 In California, ajury awarded $116
million in punitive damages to Teresa Goodrich, whose husband died of cancer
after Aetna U.S. Healthcare of California refused to pay for a bone marrow
transplant.3 Karen Johnson and Teresa Goodrich could sue their managed care
plans because their health coverage was not obtained through a benefit plan
governed by the Employee Retirement Income Security Act of 1974
*Associate Professor of Law, Louis D. Brandeis School of Law at the University
of Louisville.
1. See, e.g., Julie Marquis, Jury's Huge Award in HMO Case Renews Debate on
Patients'Rights, L.A. TIMES, Jan. 22, 1999, at A23.
2. See Kentucky Jury Delivers Blow to HMO, Awards Cancer Patient $13 Million,
MEALEY'S MANAGED CARE LIABILITY REP., Oct. 28, 1998, at.5. The jury awarded
Johnson $13 million in punitive damages, as well as $100,000 in damages for pain and
suffering and $14,046.82 for the amount she paid for the hysterectomy.
3. See Plan Liability: California Jury Awards Record Damages Against Aetnafor
Treatment Decisions, BNA's HEALTH CARE DAILY REP. (BNA), Jan. 22, 1999, at d3,
available in WL 1/22/1999 HCD d3. The jury also awarded Teresa'$4.5 million in
compensatory damages for medical expenses and loss of companionship.
[Vol. 65
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ERISA PREEMPTION
("ERISA").4 In contrast, ERISA plan participants and beneficiaries, comprising
roughly forty-four percent of the population of the United States,5 have been and
continue to be precluded from bringing comparable suits. Indeed, although
courts have narrowed the scope of preemption in recent years and have allowed
some negligence claims to proceed against managed care plans, courts continue
to hold that ERISA insulates managed care plans from liability arising from any
aspect of a benefit determination.6
Appropriately, the issue has garnered significant attention in Congress. In
1998, several federal proposals surfaced that addressed the public's concerns
stemming from the prevalent shift to managed care plans. However, only one
bill would have amended ERISA's preemption provisions to expressly permit
negligence suits against managed care plans.' Congress pledged to revisit the
4. 29 U.S.C. §§ 1001-1461 (Supp. DI 1997). ERISA was enacted to help ensure
that employee benefit plans are established on financially sound principles and to ease
the burdens that could arise from plans serving employees in more than one state. See
Michael Cohen, Note, No Faith in Bad Faith, 41 HASTINGs L.J. 201, 216 (1989).
5. See Jana K. Stain & Eleanor D. Kinney, The Road Paved With Good Intentions:
Problems and Potential for Employer-Sponsored Health Insurance Under ERISA, 31
Loy. U. Cm. L.J. 29,32 (1999) (citing U.S. GENERAL ACCOUNTING OFFICE, EMPLOYER-
BASED HEALTH PLANS: ISSUES, TRENDS, AND CHALLENGES POSED BY ERISA 2 (1995)).
6. See, e.g., Hull v. Fallon, 188 F.3d 939 (8th Cir. 1999), cert. denied, 120 S. Ct.
1242 (2000); Parrino v. FHP Inc., 146 F.3d 699 (9th Cir. 1998); Turner v. Fallon
Community Health Plan, 127 F.3d 196 (1st Cir. 1997); Tolton v. American Biodyne,
Inc., 48 F.3d 937 (6th Cir. 1995); Huss v. Green Spring Health Servs., Inc., 18 F. Supp.
2d 400 (D. Del. 1998); Benoit v. W.W. Grainger, Inc., No. Civ.A 98-1315, 1998 WL
749444 (E.D. La. Oct. 21, 1998); Andrews-Clarke v. Travelers Ins. Co., 984 F. Supp. 49
(D. Mass 1997). See also Karen A. Jordan, Tort Liability for Managed Care: The
Weakening ofERISA's Protective Shield, 25 J. L. MED. & ETHICS 160,167 &169 (1997)
(explaining that, regardless of the reason for a denial of coverage, the trend is and has
been that any and all claims arising from benefit determinations are generally found to
be preempted). But see infra note 14 (noting that courts are more receptive to claims
challenging negligent selection of providers in the plan network, negligent policies that
affect the provision ofmedical care, and negligent provision of medical advice by agents
of the managed care plan. See, e.g., Crum v. Health Alliance-Midwest, Inc., 47 F. Supp.
2d 1013 (C.D. Ill. 1999); Delucia v. St. Luke's Hosp., No. Civ.A 98-6446, 1999 WL
387211 (E.D. Pa. May 25, 1999)).
7. The Democratic leadership proposal would have amended § 514(a) of ERISA
by adding a subsection providing generally that ERISA shall not:
[S]upersede any cause of action under state law to recover damages resulting
from personal injury or for wrongful death against any person: (A) in
connection with the provision of insurance, administrative services, or
medical services by such person to or for a group health plan; or (B) that
arises out of the arrangement by such person for the provision of such
insurance, administrative services, or medical services by other persons.
S. 1890, 105th Cong. (1998); H.R. 3605, 105th Cong. (1998).
The proposal included an express exception for employers or other plan sponsors.
2000]
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issue of managed care legislation in 1999. This time, several bills emerged that
would have allowed suits (of varying scope) against managed care plans.' On
October 7, 1999, the House passed the Norwood-Dingell bill, which broadly
exempts from ERISA preemption state law causes of action arising from
managed care activities, including denials of coverage.9 However, the fate of the
Norwood-Dingell bill is uncertain because the Senate passed a managed care
reform bill in July 1999 that did not contain any provision allowing suits against
managed care plans.'0 Further, the Norwood-Dingell bill never won the support
of House leadership." It is thus unclear whether the House provision will
survive the conference committee process.
The purpose of this Article, in part, is to provide some guidance to the
debate. The Article first explains the scope of the preemption problem for
ERISA plan participants and beneficiaries in cases involving coverage denials
and introduces the reader to the legislative solution passed by the House. The
Article then explores whether federal legislation is necessary to address the
problem, in light of narrowing interpretations of the scope of ERISA preemption
by the judiciary. This question necessarily requires an assessment of the
soundness of the narrower view of preemption, as well as of the extent to which
Specifically, the proposal provided that the amendment would not authorize "(i) any
cause of action against an employer or other plan sponsor maintaining the group health
plan, or (ii) a right of recovery or indemnity by a person against an employer or other
plan sponsor for damages assessed against the person pursuant to [the state cause of
action exempted from § 514(a) preemption]." In contrast, none of the Republican
proposals would have changed the current scope of ERISA preemption. See H.R. 4250,
105th Cong. (1998) (House Republican Leadership Bill); S. 2330, 105th Cong. (1998)
(Senate Republican Leadership Bill); S. 2416, 105th Cong. (1998) (Senate Centrists
Bipartisan Plan). An early version of federal managed care regulation proposed to amend
ERISA to create a federal action under § 502(a). This proposal disappeared from the
more intense debates during the summer of 1998. See H.R. 1749, 105th Cong. (1998)
(sponsored by Rep. Pete Stark (D-Cal.)).
8. For a discussion of the 1999 proposals, see infra notes 112-27 and
accompanying text.
9. See H.R. 2723, 106th Cong. (1999). The bill is titled "Bipartisan Consensus
Managed Care Improvement Act of 1999." H.R. 2723 § l(a). After passage of the
Norwood-Dingell bill, the House passed a Republican package of tax breaks and
insurance reforms, H.R. 2990, 106th Cong. (1999), designed to increase access to health
care coverage. Following that vote, the Norwood-Dingell bill was merged with the
access bill. The combined bill kept the bill number of the access measure. See Plan
Regulation: GOP Leaders Fail to Name Norwood, Ganske to Conference on Managed
Care Legislation, HEALTH CARE DAILY (BNA), Nov. 4, 1999, at d3, available in WL
11/4/1999 HCD d3.
10. See Plan Regulation: Managed Care Reforin Faces Next Hurdle: Conferees
Likely to Oppose House-Passed Bill, HEALTH CARE DAILY (BNA), Oct. 12, 1999, at d2,
available in WL 10/12/1999 HCD d2.
11. See infra note 125 and accompanying text.
[Vol. 65
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the narrower view resolves the preemption problem. The analysis concludes that
a federal legislative solution is preferable because, although the emerging view
of preemption might permit state law claims challenging coverage decisions
based on medical decision making, state law claims that would provide an
incentive for managed care plans to act fairly would likely remain preempted.
In addition to contributing to the debate regarding the proposed federal
legislation, this Article seeks to explain in detail why, in contrast to the prevalent
trend, courts should now find that Congress did not intend for ERISA to preempt
all state law claims challenging any aspect of coverage decisions by managed
care plans. Rather, case law now supports the argument that a common law
claim seeking recovery for harms arising from a negligent medical decision
represents a distinct type of state law claim that does not warrant preemption.
If the House bill does not survive the conference committee process, the analysis
presented in this Article may be useful to courts as they continue to grapple with
the scope of ERISA preemption.
II. THE SCOPE OF THE PREEMPTION PROBLEM IN CASES
INVOLVING COVERAGE DENIALS
Coverage denials are an inevitable consequence of the financing systems
used by Americans to pay for health care services. Even under the traditional
indemnity model of health insurance, coverage denials were an integral part of
the system. However, concern over coverage denials has dramatically increased
due to the shift to managed care because managed care has changed the nature
of the claims denial process. Under managed care, physical injury is more likely
to be a consequence of a coverage denial. The problem for ERISA plan
participants and beneficiaries has been their inability to hold managed care plans
accountable when coverage decisions have caused harm, even when the denial
was based on an exercise of medical judgment as opposed to mere contractual
interpretation.
As noted, ERISA plan participants and beneficiaries, unlike Karen Johnson
and Teresa Goodrich, have been precluded from bringing lawsuits against their
managed care plans for injuries stemming from coverage decisions. The
preclusion of such lawsuits is a consequence of a provision in ERISA that
expressly preempts state laws that "relate to" ERISA plans.' ERISA's
preemption provision has historically been viewed expansively. Consequently,
any state tort or contract claim that in any way arises from a health benefit
determination for a participant or beneficiary in an ERISA plan has been held to
12. Section 514(a) of ERISA prescribes that ERISA "shall supersede any and all
State laws insofar as they may now or hereafter relate to any employee benefit plan." 29
U.S.C. § 1144(a) (Supp. 11 1997). For an overview of ERISA's preemption provisions,
see generally Karen A. Jordan, Travelers Insurance: New Support for the Argument to
Restrain ERISA Pre-emption, 13 YALE J. ON REG. 255 (1996).
2000]
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be preempted. 3 Although courts have narrowed the scope of preemption in
recent years-thereby permitting some tort claims against managed care
plans -- most courts continue to find preempted any state law claim involving,
in any way, a coverage denial." And this is true notwithstanding the fact that
coverage denials can be based on different reasons or the fact that some tort
claims effectively regulate the quality of health care. Thus, appreciating the
scope of the preemption problem in cases involving coverage denials requires
an explanation of the different types of coverage denials in managed care plans,
as well as an explanation of the leading preemption cases involving state
common law actions arising from coverage denials. 6
13. See Jordan, supra note 12, at 261-70 (discussing the scope of ERISA's
preemption provisions prior to 1995).
14. For example, because they are further removed from the processing of claims
for benefits, courts have become receptive to the argument that ERISA does not preempt
claims challenging negligent selection of providers in the plan network, negligent
policies that affect the provision of medical care, and negligent provision of medical
advice by agents of the managed care plan. See, e.g., Crum v. Health Alliance-Midwest,
Inc., 47 F. Supp. 2d 1013, 1018 (C.D. IM. 1999) (holding that ERISA does not preempt
state common law claims arising from advice provided by the managed care plan's
"advisory nurse"); Delucia v. St. Luke's Hosp., No. Civ.A 98-6446, 1999 WL 387211
(E.D. Pa. May 25, 1999) (holding that ERISA does not preempt state common law claims
challenging a managed care plan's policies that caused a treating physician to negligently
fail to order a breathing monitor).
15. See, e.g., Hull v. Fallon, 188 F.3d 939, 943 (8th Cir. 1999) (holding preempted
state law claims arising from the plan administrator's decision to deny coverage for a
thallium stress test, and to recommend a treadmill test instead), cert. denied, 120 S. Ct.
1242 (2000); Parrino v. FHP, Inc., 146 F.3d 699, 704-05 (9th Cir. 1998) (holding
preempted state law claims arising from a managed care entity's allegedly wrongful
initial denial of coverage for proton beam therapy upon a utilization review finding that
the treatment was experimental and unnecessary); Turner v. Fallon Community Health
Plan, Inc., 127 F.3d 196, 199-200 (1st Cir. 1997) (holding preempted a state law claim
that a managed care entity wrongfully denied coverage for a type of bone marrow
transplant and high dose chemotherapy treatment-although this case may not have
given rise to a tort claim); Huss v. Green Spring Health Servs., Inc., 18 F. Supp. 2d 400,
408-09 (D. Del. 1998) (holding preempted a state tort claim that a managed care plan
negligently failed to verify coverage and refused to cover treatment for a psychiatric
disorder); Andrews-Clarke v. Travelers Ins. Co., 984 F. Supp. 49 (D. Mass. 1997)
(holding preempted claims that a managed care entity repeatedly and negligently refused
to authorize inpatient rehabilitation and detoxification treatment).
16. Notably, some decisions suggest that the crucial factor in the preemption
analysis is how the plaintiff has pleaded her claim. For example, in Delucia, 1999 WL
387211, at * 1, the plaintiff sought to hold a managed care plan vicariously liable for
injuries caused by the treating physician's decision to discharge an infant from the
hospital without a breathing monitor. Id. The physician advised Delucia that the infant's
condition did not meet the managed care plan's criterion for discharging a newborn on
a breathing monitor. The defendant managed care plan argued that the plaintiff's claim
was for a "denial of benefits" and thus preempted. Id. The court disagreed, noting:
[Vol. 65
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A. Coverage Denials Before Managed Care-Contractual in Nature
Historically, health coverage was predominantly provided through Blue
Cross and Blue Shield service benefit plans or commercial indemnity insurance
plans. Under Blue Cross plans, providers elected to participate in the plan, and
thus to provide services for enrollees and to accept the plan's payments for
services. 17 Blue Cross and Blue Shield plans, then, have always involved a
relationship or agreement with "participating providers," but the plans did not
attempt to influence the provision of health care.18 Blue Cross reimbursed
hospitals on the basis of "reasonable costs." Costs included virtually any
expense, and Blue Cross rarely questioned the reasonableness of costs. 9 Blue
Shield reimbursed physicians on the basis of "customary fees" for particular
procedures in particular areas.20 Under traditional indemnity plans, patients
selected a health care provider, paid the provider's bill, and then sought
reimbursement from the plan. In contrast to Blue Cross and Blue Shield plans,
indemnity plans had no financial or other relationship with the providers.21 To
ensure provider cooperation in commercial plans, insurers tracked the
When a plaintiff fails to allege that the denied or omitted medical treatment
or service was due under the plan, preemption does not apply. Plaintiffs here
nowhere allege that Aetna denied a request for a breathing monitor. Nor do
they allege either that the [infant's] condition, in fact, met the plan's criterion
... or even that a breathing monitor was covered by the plan.
Id. at *3 (citation omitted).
However, preemption is not a matter of pleading. Rather, the crucial factor is
whether the claim arises from a coverage denial. In Delucia, no one ever presented to
Aetna a request for a breathing monitor for the infant. Thus, a denial of coverage did not
occur. The fact that a claim results from a coverage denial is the crucial factor in the
preemption analysis.
.17. Whereas indemnity plans viewed themselves as selling insurance, Blue Cross
plans viewed themselves as selling "prepaid health care." See RAND E. ROSENBLATr ET
AL., LAW AND THE AMERIcAN HEALTH CARE SYSTEM 9 (1997).
18. Blue Cross plans were controlled by the American Hospital Association, and
Blue Shield plans were controlled by state medical societies. See ROSENBLATr ET AL.,
supra note 17, at 10.
19. See ROSENBLATT ET AL., supra note 17, at 469 (explaining that Blue Cross
determined only whether costs were "allowable"; and that allowable costs included
"salaries, costs of medical education, capital costs, depreciation, interest, legal fees,
public relations, bad debts, and a plus factor for items that might have been omitted from
the list of allowable costs").
20. See ROSENBLATr ET AL., supra note 17, at 514-15 (explaining that physicians
historically were paid on a fee-for-service basis, often using a fee schedule; and that Blue
Shield would pay the lesser of the individual physician's actual billed charge, the
customary charge, or the prevailing charge in the community).
21. See ROSENBLATTET AL., supra note 17, at 553-54.
2000]
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reimbursement policies of Blue Cross and Blue Shield.' Both plans limited
benefits to "medically necessary" care, but in practice the companies rarely
questioned the medical judgment of providers.23
Under the historical system, then, coverage decisions were made
retrospectively, after the health care had been provided to the patient. In
commercial indemnity plans, the decision was made when the claimant sought
reimbursement from the plan. In Blue Cross and Blue Shield plans, the decision
was made when the provider submitted a claim for payment. Because
commercial insurers and Blue Cross and Blue Shield rarely questioned medical
necessity, there was no advantage in making coverage decisions before or during
the course of the treatment. Further, the fact that medical necessity was rarely
questioned meant that denials resulted only if the claim was improperly filed or
if the service was not "covered"--for some reason other than medical necessity.
For example, a claim might be denied if (1) the service did not fall within a
category of services covered by the policy, (2) the service fell within the scope
a specific exclusion in the policy, or (3) the service exceeded the quantity
allowed under the policy. Thus, the reasons underlying a coverage denial before
managed care tended to be more purely contractual in nature.
B. Coverage Denials in Managed Care Plans
1. The Basics of Managed Care
It is well recognized that managed care plans have become a dominant force
in our health care system.24 Managed care has proliferated because of its
promise to contain the costs associated with health care delivery under the
traditional "reasonable cost" and "fee-for-service" paradigms.25 Cost savings in
22. See ROSENBLATrET AL., supra note 17, at 13.
23. See ROSENBLATr ET AL., supra note 17, at 13 (explaining that, in the era of
provider-dominated financing, "[t]here was no serious, independent review of doctors
and hospitals regarding which patients they chose to serve, or for quality or volume of
care, and private insurers would pay doctors and hospitals pretty much what they
asked").
24. It has been reported that, as of 1995, 78% of all privately insured persons were
members of managed care plans. Further, by 1996, one third of the nation's nearly 36
million Medicaid beneficiaries, and 9% of the Medicare population, were enrolled in
some form of managed care. See ROSENBLATT ET AL., supra note 17, at 544; see also
Gail A. Jensen et al., The New Dominance of Managed Care: Insurance Trends in the
1990s, 16 HEALTH AFFAIRS 125 (1997).
25. Managed care has been broadly defined as any system:
[T]hat integrates the financing and delivery of appropriate health care services
to covered individuals [by] arrangements with selected providers to furnish
a comprehensive set of health care services... explicit standards for selection
of health care providers; formal programs for ongoing quality assurance and
[Vol. 65
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managed care result from the integration of health care financing and delivery.
This is often explained by noting that managed care plans act in a dual capacity:
First, [plans assume] the role of an insurance company by defining and
determining the parameters as to the level and extent of health care
that will be provided in exchange for the 'premiums,' 'dues,' or
'membership fees.' Second, [plans establish] the 'network' or system
of medical care providers to actually render the medical care covered
under the established parameters.26
More specifically, however, cost savings are achieved because of the
controls that managed care plans can exert over health care providers in
exchange for allowing providers to be part of the network." The primary
objectives of the controls are to prevent the provision of "unnecessary" medical
care.2" Utilization review ("UR") is the most notorious practice used by
managed care plans to stem the provision of unnecessary care.29 UR involves a
utilization review; and significant financial incentives for members to use
providers and procedures associated with the plan.
HEALTH INSURANCE ASS'N OF AMERICA, SOURCE BOOK OF HEALTH INSURANCE DATA 18
(1991).
26. See Sharon J. Arkin, A Litigator's Perspective on HMO Liability: The View
from the Plainti~s Side, 22 AM. J. TRIAL ADVOC. 131, 134 (1998). Professor Furrow has
explained:
Managed care is usually distinguished from traditional indemnity plans by the
existence of a single entity responsible for integrating and coordinating the
financing and delivery of services were once scattered between providers and
payers. This entity provides comprehensive health care services to an
enrolled membership for a fixed per capita fee, thus becoming both an insurer
and a provider of medical care. This risk bearing is then distributed
downstream to physician providers through capitation contracts.
See Barry R Furrow, Managed Care Organizations and Patient Injury: Rethinking
Liability, 31 GA. L. REv. 419, 430 (1997) (footnotes omitted).
27. To date physicians, out of fear of being left out of networks and thus of losing
access to significant volumes of patients, have entered into contracts with managed care
organizations "almost indiscriminately." See William M. Sage, Enterprise Liability and
the Emerging Managed Health Care System, 60 LAw & CONTEMP. PROBS. 159, 193
(1997).
28. Practices include UR, capitation payment, and financial incentives. For a
description of UR, see infra notes 29-31 and accompanying text. Capitation refers to a
reimbursement system in which a managed care plan compensates a contracting
physician at a flat rate for each patient enrolled in the plan for a specified period of time.
Financial incentives include strategies such as risk pools, bonuses, and expanded
capitation to decrease the use of referrals, diagnostic tests, and other services. See
generally Stephen R. Latham, Regulation of Managed Care Incentive Payments to
Physicians, 22 AM. J. L. & MED. 399 (1996).
29. UR is a subset of the broader concept of utilization management ("UM"). As
2000]
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comparison of services being provided or proposed to be provided to a patient
"with established criteria developed from information obtained from comparable
patients in order to determine if. . .health care services are medically
necessary."3 Thus, in contrast to the historical approach to coverage, a central
tenet of managed care is to question the medical judgment of providers.
UR can be prospective, concurrent, or retrospective. Prospective UR is
performed prior to the administration of the recommended treatment; concurrent
UR occurs during the course of the treatment; and retrospective UR occurs after
medical treatment is rendered. As noted, retrospective review, even if based on
the issue of medical necessity, tends to impact only a question of coverage
because the health care has already been provided to the patient.
In contrast, prospective and concurrent UIR often impact whether the
recommended health care services are actually provided to the patient because
patients often cannot afford the medical care recommended by their treating
physician but denied by their managed care plan. Hence, concurrent and
prospective UR are the linchpins of managed care. Most managed care plans
follow a similar process in conducting concurrent or prospective UR.
[The UR] process entails a review of the subscriber's case, usually by
a registered nurse, who analyzes the care or procedures proposed or
provided in order to determine whether they fall within the managed
care entity's utilization standards. After this initial analysis has been
completed and it has been determined that the treatment is not within
the standards, the case is presented to a [UR] physician or medical
director for further analysis. If, after consultation with the subscriber's
physicians, it is determined that the care is not medically necessary,
payment will not be authorized. In the event it is determined that the
requested service is not medically necessary and thus not covered
under the policy, the subscriber can elect to pay for the service out of
pocket or pursue an appeal of the decision.3'
one article has explained:
Today, UM is conducted by insurance companies, third party administrators,
managed care entities, and private companies that provide specialized UM
services. UM in these areas involves a myriad of functions. Techniques
include monitoring the practice patterns of providers, case management of
high cost cases, referral management, and service and coverage authorization.
Brian P. Battaglia, The Shift Toward Managed Care and Emerging Liability Claims
Arisingfrom Utilization Management and Financial Incentives Arrangements Between
Health Care Providers and Payers, 19 U. ARK. LITTLE ROCK L.J. 155, 170-71 (1997)
(footnotes omitted).
30. Id. at 171 (citing PROSPECTIVE PAYMENT ASSESSMENT COMMISSION, HEALTH
CARE FINANCING ADMINISTRATION, 104TH CONG., MEDICARE AND THE AMERICAN
HEALTH CARE SYSTEM, REPORT TO CONGRESS 80-81 (1995)).
31. Id. at 172. Battaglia states:
[Vol. 65
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Managed care plans stress that policyholders can elect to pay for the service out
of pocket in order to support their position that the UR determination is simply
a "coverage issue" and not medical decision making. But, the essence of the UR
determination in many cases is whether the recommended medical service or
treatment is medically necessary; and, thus, the reviewer is engaging in medical
decision making. Further, because prospective and concurrent UR often impact
whether the enrollee actually proceeds with recommended treatments, managed
care plans' medical decision making has a great potential to cause harm.
2. Managed Care-The Injection of Medical Decision Making
into the Coverage Decision
With the advent of managed care, then, the reasons for coverage denials
have multiplied. Coverage denials before managed care generally resulted only
if the claim was improperly filed or if the service was not "covered" for some
contractual reason. For example, a claim might be denied if(1) the service did
not fall within a category of services covered by the policy, (2) the service fell
within the scope a specific exclusion in the policy, or (3) the service exceeded
the quantity allowed under the policy. In contrast, coverage denials in managed
care health plans may be based on conduct involving an application of medical
judgment in addition to conduct involving contractual interpretation or
application.
More specifically, a denial by a managed care plan generally still is based
on one of two reasons: the claim for coverage was improperly filed, or the
service is not covered by the policy. The three contractual reasons noted in the
prior paragraph which tended to underlie a coverage decision before managed
care remain as possible reasons for a denial after managed care. But managed
care gives rise to additional reasons: Under managed care, a service may not be
covered because (1) the service was improperly accessed, e.g., the claimant
obtained the service from a nonparticipating provider or without pre-approval,
or (2) the service, although falling within a covered category of services
generally, is not covered in a given case because it is deemed to be "not
medically necessary" or "experimental."
A denial based on a finding that the service is not medically necessary is
distinct from all of the other noted reasons. A decision that a service is not
covered in a given case because it is deemed to be "not medically necessary" or
Sources relied upon in [UR] include the Appropriateness Evaluation Protocol,
Intensity of Service, Severity of Illness, Discharge and Appropriateness
Screening Criteria, and the Standardized Medreview Instrument. These
standards evolved from programs funded by the government to develop
criteria for the [Medicare peer review organizations]. In addition, databases
have been developed commercially for use in the [UR] process.
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"experimental" involves medical decision making. 2 As other scholars have
aptly explained, a medical necessity determination also involves the injection of
a value judgment, i.e., a judgment as to whether a particular procedure is worth
performing given the cost and expected health outcome.33 But the essence of the
decision involves medical decision making.
Indeed, recent judicial decisions have specifically recognized that persons
making UR determinations are making medical decisions. In Murphy v. Board
ofMedical Examiners,34 the Court of Appeals of Arizona held that an individual
who made decisions authorizing or denying pre-certification of medical
procedures was engaged in the practice of medicine and thus subject to the
jurisdiction of the Arizona Board of Medical Examiners. 35 According to the
court,
Dr. Murphy evaluated information provided by both the patient's
primary care physician and her surgeon. He disagreed with their
decision that gall bladder surgery would alleviate her ongoing
symptoms. S.B.'s doctors diagnosed a medical condition and
proposed a non-experimental course of treatment. Dr. Murphy
substituted his medical judgment for theirs and determined that the
surgery was "not medically necessary." There is no other way to
characterize Dr. Murphy's decision: it was a "medical decision. 35
32. For purposes of clarity, this Article will henceforth speak only in terms of
determinations of medical necessity, rather than continuing to reference determinations
of whether particular treatment or care should be deemed "experimental." As with
determinations of medical necessity, whether medical care or treatment is experimental
often involves an exercise of medical knowledge and judgment.
33. Professor Patricia Danzon has explained:
At best, medical science may be able to tell us the probability distribution of
health outcomes and risks from a given treatment. To decide whether a
particular procedure is worth performing requires comparing the value of the
expected health outcomes to costs. Valuation of medical services ultimately
depends on consumer preferences for alternative outcomes, including
tolerance for risk and discomfort, preferences for health care versus other
goods, and so forth. Thus, 'medical judgment' alone cannot provide a basis
for evaluating a particular cost containment mechanism or coverage decision.
Patricia M. Danzon, Tort Liability: A Minefieldfor Managed Care?, 26 J. LEGAL STUD.
491, 508 (1997) (footnotes omitted); see also Peter A. Glassman et al., The Role of
Medical Necessity and Cost-Effectiveness in Making Medical Decisions, 126 ANNALS OF
INTERNAL MEDICINE 152 (1997).
34. 949 P.2d 530 (Ariz. Ct. App. .1997).
35. Id. at 535-36; cf Morris v. D.C. Bd. of Med., 701 A.2d 364 (D.C. 1997).
36. Murphy, 949 P.2d at 536. The court recognized the significant policy issues
arising as a result of its holding. On the one hand, its decision might prompt a "flood of
complaints by disgruntled doctors and patients who dispute the insurer's denial of
benefits as 'not medically necessary."' On the other, a failure to find that Murphy
[Vol. 65
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In a different context, the court in Long v. Great West Life & Annuity Insurance
Co.,' 7 similarly held that UR involves "medical decision making" and thus is
distinguishable from the traditional process of determining "insurance claims and
coverage. 38
Therefore, health care coverage denials in the managed care environment
can be characterized as falling into two distinct categories: (1) denials arising
from conduct that involved an exercise of medical judgment, and (2) denials
arising from conduct that involved contractual interpretation or application, but
not an exercise of medical judgment.
3. Discerning the Basis for the Coverage Denial
Unfortunately, the categorization just described is complicated by the
realities of health coverage contracting. Managed care plans generally define the
term "medical necessity" in their policies. As a result, coverage denials based
on a finding that the recommended treatment is "not medically necessary" could
fall into either category. Some health coverage policies do not define the phrase
medically necessary and simply cover certain medical services as long as a
utilization reviewer agrees with the treating physician's determination that a
certain covered service is "medically necessary" or "reasonable and necessary."
engaged in the practice of medicine might "frustrate consumers who purchase health
insurance yet find themselves facing a stone wall when their insurer opposes their
physicians' treatment recommendations." Id. The court left the policy issues to the
legislature.
37. 957 P.2d 823 (Wyo. 1998). In Long, one issue was whether the plaintiff, a
state employee who obtained coverage through his employment, was required to exhaust
the administrative procedures set forth in the statutory provisions and administrative rules
governing state insurance programs. An administrative rule stated that the grievance
procedures established through the rules and regulations "provide the exclusive
administrative remedy available to state employees .. .in adjudicating disputes
concerning insurance claims and coverage." Id. at 832. The court held that the rule did
not preclude the plaintiff's judicial action against the insurance company that
administrated the state health plan.
38. Id. However, Ohio's attorney general recently issued an opinion finding that
"actions taken by a health-insuring corporation are not considered to constitute the
practice of medicine," under Ohio law, and thus the Ohio State Medical Board could not
discipline a medical director employed by an insurance company as a result of a medical
necessity determination. See Doctors Doing UR Not Practicing Medicine, Ohio AG
Rules; Medical Board in Quandry, HEALTH L. REP. (BNA), Sept. 16, 1999, at 1500.
Interestingly, the attorney general noted that, as a result of her opinion, the Ohio
legislature may want to revisit the issue of whether patients should be able to sue their
HMOs for denying coverage: "If these doctors aren't accountable to the medical board,
and patients can't sue their HMOs, what other course of action does a physician or
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When such policies are involved, all denials based on a finding that, in a given
case, the recommended treatment is "not medically necessary" would involve an
exercise of medical judgment. Other policies, however, may have specialized
definitions of what constitutes "medically necessary" or "reasonable and
necessary." For example, in one well known case, the coverage policy defined
"medically necessary" as that care or treatment
[(i)] required and appropriate for care of the Sickness or Injury; and
that [(ii)] are given in accordance with generally accepted principles
of medical practice in the U.S. at the time furnished; and that [(iii)] are
approved for reimbursement by the Health Care Financing
Administration; and that [(iv)] are not deemed to be experimental,
educational or investigational in nature by any appropriate
technological assessment body established by any state or federal
government; and that [(v)] are not furnished in connection with
medical or other research. 9
A tort action arising in connection with a denial of coverage under this definition
ofmedical necessity could be characterized as an action challenging conduct that
involved contractual interpretation or application. Further, application of some
of the clauses of the provision would not require an exercise of medical
judgment, e.g., clauses (iii) and (iv). However, application of some of the
clauses would require an exercise of medical judgment, e.g., clauses (i), (ii), and
perhaps (v). 40
The Goodrich and Johnson suits aptly illustrate that there are differences in
the types of suits which may arise from a coverage denial. Karen Johnson, a
thirty-five year old woman, was diagnosed with IN-SITU carcinoma of the
cervix with endocervical gland extension. Her physicians recommended a
hysterectomy, as this treatment more dramatically reduced the risk that the
cancer might return. Johnson's insurer, Humana, disagreed that a hysterectomy
was medically necessary. Humana approved payment for a cheaper, less
invasive procedure called a cervical conization. Johnson appealed twice to
Humana for coverage for the treatment recommended by her physicians, but was
denied both times.4 She therefore used $14,000 of her family's money to pay
39. See Fuja v. Benefit Trust Life Ins. Co., 18 F.3d 1405, 1408 (7th Cir. 1994).
40. Thus, because the theory explained in Part V of this Article is that ERISA does
not preempt state tort actions challenging a managed care plan's negligent medical
decision making, litigants must carefully develop the relevant facts and courts must
carefully discern exactly what type of conduct is being challenged when the defense of
ERISA preemption is raised in tort actions.
41. During the trial, Humana argued that three independent board-certified
gynecologists reviewed Johnson's claim and determined that a hysterectomy was not
medically necessary. However, Johnson's attorneys argued that Humana's claims
reviewer, Value Health Systems in California, determined that the hysterectomy was not
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for the hysterectomy.42 In this type of scenario, a tort suit challenging the denial
would be aimed at conduct involving an exercise of medical judgment.43
Teresa Goodrich's suit arose from different circumstances. Her husband,
David, was diagnosed with a rare type of stomach cancer. Because no Aetna
physicians were equipped to treat David's cancer, his primary care physician
authorized out-of-network visits with cancer treatment specialists who eventually
recommended that he undergo a bone marrow transplant. Aetna refused to pay
for the procedure or for any of David's visits to out-of-network physicians,
purportedly because David sought treatment outside the Aetna plan without first
obtaining approval from Aetna's medical director. Aetna recommended that
David begin chemotherapy supervised by in-plan physicians," even though
Aetna conceded that its network physicians were inexperienced with the rare
form of stomach cancer involved.45 But Aetna made other statements: first, that
David's policy explicitly excluded the bone marrow transplant 6 and, second,
that David was never an appropriate candidate for high-dose chemotherapy due
to the progression of the disease.47 Thus, it is not entirely clear to what extent
the denial of coverage may have been attributable to an exercise of medical
judgment. However, some of the noted reasons, such as David's alleged failure
to obtain plan approval, would give rise to a claim challenging conduct involving
contract interpretation or application other than an exercise of medical judgment.
That type of claim is distinguishable from the type of claim in the Johnson case.
medically necessary without properly examining Johnson's medical file or her health care
contract. See Kentucky: Humana to Pay Patient $13 Million For Denying Hysterectomy,
Jury Decides, HEALTH L. REP. (BNA), Oct. 29, 1998, at 1723-24.
42. See Kentucky Jury Delivers Blow to HMO, Awards Cancer Patient $13 Million,
MEALEY'S MANAGED CAR LIABIm'Y REP., Oct. 28, 1998, at 5; Humana Asks Judge to
Throw Out $13.1 Million Verdict; HMO Did Nothing Wrong in Woman's Case,
COURiER-JOURNAL (Louisville), Dec. 22, 1998, at 01B.
43. Professor Danzon has advocated pursuing denials under contract rather than
tort principles. See supra note 33. However, the premises underlying her argument do
not reflect the reality of the relationship between the managed care plan and the
policyholder/patient.
44. See California HMO Case Moves Toward Trial After Surviving Arbitration,
ERISA Hurdles, MEALEY'S MANAGED CARE LIABILITY REP., Nov. 25, 1998, at 13.
45. See Julie Marquis, Sending a Signal: HMO Hit With Nation's Largest Verdict:
California Cancer Victim's Widow is Awarded $120 Million, SEATTLE TIMES, Jan. 21,
1999, at A15.
46. See California HMO Case, supra note 44, at 13 (noting that Aetna explained
that "[s]ervices from non-participating providers, including self-referral to participating
providers, are excluded from coverage, except in the case of medical emergency or when
authorized in advance by the plan's medical director").
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4. Why the Distinction Is Important
The distinction between types of denials may seem unimportant if ERISA
precludes plan participants and beneficiaries from holding managed care plans
accountable for harm caused by coverage decisions-even when the denial was
based on an exercise of medical judgment as opposed to mere contractual
interpretation. However, understanding that different types of conduct underlie
coverage denials helps one appreciate the scope of the preemption problem.
Further, understanding the distinction helps one understand the evolution of
preemption case law. An early Supreme Court case held that ERISA preempted
state common law actions challenging the processing of a claim for benefits;
however, in that case, the conduct did not involve an exercise of medical
judgment.48 The Fifth Circuit extended preemption to actions challenging
coverage denials based on conduct that did involve an exercise of medical
judgment.49 Today, most courts steadfastly continue to follow the Fifth Circuit
view and hold that ERISA preempts any state tort or contract" claim which in any
way arises from a health coverage determination-even if the denial was based
on an allegedly negligent exercise of medical judgment.
li light of more recent Supreme Court decisions delimiting the scope of
ERISA preemption, however, the issue becomes whether preemption should
continue to be extended to cases arising from denials based on determinations
of medical necessity.50 Indeed, under an emerging view of preemption, courts
may find that ERISA does not preempt tort actions challenging a managed care
plan's failure to use reasonable care when making medical decisions, or other
tort actions constituting state regulation of the quality of health care. If this view
of ERISA preemption is valid-thereby opening the door to at least some
lawsuits that arise from coverage denials that result in harm-the issue then
48. See Pilot Life Ins. Co. v. Dedeaux, 481 U.S. 41 (1987); see also infra notes 65-
75 and accompanying text.
49. See Corcoran v. United Healthcare, Inc., 965 F.2d 1321 (5th Cir. 1992), cert.
denied, 506 U.S. 1033 (1992); infra notes 77-93 and accompanying text.
50. These developments include a trilogy of Supreme Court cases which, among
other things, have prompted lower courts to take a more pragmatic or purposive approach
to preemption rather than viewing ERISA as broadly preempting any state law with any
"relation to" ERISA plans. Additionally, lower courts have modified their approach to
the question of preemption of state common law tort actions against managed care plans
by recognizing that actions challenging the quality of medical care are not preempted.
However, courts have continued to follow Corcoran and thus continue to find that
ERISA precludes tort suits challenging the quality of a JR decision that medical care or
treatment recommended by a treating physician is not "medically necessary"--because
those actions also involve a benefit determination and thus challenge the quantity of
benefits received as well. Importantly, the defendant in such cases generally would be
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becomes whether a federal amendment to ERISA is necessary. Before
addressing those questions, however, it is first helpful to review why lower
courts so readily extended ERISA preemption to state tort actions seeking
damages for injuries caused by allegedly negligent coverage denials based on
conduct involving an exercise of medical judgment.
III. PREEMPTION OF STATE LAW CHALLENGES ARISING FROM
COVERAGE DENIALS
Understanding why ERISA has been construed as preempting all state
common law suits arising in any way from a coverage denial requires an
understanding of the Supreme Court's early preemption cases, especially Pilot
Life Insurance Co. v. Dedeaux;5' as well as an understanding of the Fifth
Circuit's landmark decision in Corcoran v. United Healthcare, Inc.,52 which
extended ERISA preemption to state tort actions seeking damages for injuries
caused by allegedly negligent coverage denials based on conduct involving an
exercise of medical judgment. Importantly, Corcoran was decided at a time
when the Supreme Court precedent suggested an expansive and practically
unlimited view of ERISA preemption.53
A. Pilot Life and the Traditional Broad View of ERISA Preemption
ERISA was enacted in 1974 to protect the interests of participants and their
beneficiaries in employee benefit plans, primarily by establishing standards for
disclosure and reporting, and various fiduciary responsibilities.54 Congress
included a preemption provision to ensure uniform regulation of plans
administered in more than one state, arguably because this would facilitate the
formation and maintenance of plans.55 Section 514(a) of ERISA ("§ 514(a)")
prescribes that ERISA "shall supersede any and all State laws insofar as they
may now or hereafter relate to any employee benefit plan .... While the full
51. 481 U.S. 41 (1987).
52. 965 F.2d 1321, 1334 (5th Cir. 1992), cert. denied, 506 U.S. 1033 (1992).
53. See infra notes 54-75 and accompanying text.
54. See 29 U.S.C. § 1001(b) (1994).
55. Fort Halifax Packing Co. v. Coyne, 482 U.S. 1, 9-11 (1987).
56. 29 U.S.C. § 1144(a) (1994).
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scope of ERISA preemption is modified by the savings and deemer clauses,57 the
outer boundary of ERISA preemption is guided by the "relates to" language.
The history of ERISA preemption and the early Supreme Court construction
of the "relates to" language has been well chronicled, and there is no need for an
expansive treatment of the subject in this Article. 8 It is sufficient to emphasize
a few key points about how courts viewed ERISA preemption at the time
Corcoran was decided. Prior to 1995, Supreme Court cases broadly interpreted
the phrase "relates to" as encompassing any state law that had "a connection
with or reference to" an ERISA plan.59 The Court had stated that ERISA
preemption extends beyond state laws specifically directed at employee benefit
plans or laws dealing with the subject matters covered by ERISA6° to reach even
state laws that are consistent with ERISA's purpose.6' The Court left room for
some limitation on the breadth of ERISA preemption by noting that preemption
would not result if a state law has only a "tenuous, remote, or peripheral"
connection with covered plans.62 However, until 1995, when the Supreme Court
decided New York State Conference of Blue Cross & Blue Shield Plans v.
57. ERISA's savings clause exempts from preemption any law that regulates
insurance, banking, or securities. 29 U.S.C. § 1144(b)(2)(A) (1994). ERISA's deemer
clause modifies the savings clause by prescribing that employee benefit plans may not
be characterized as an insurance company and regulated by the state through insurance
laws. 29 U.S.C. § 1144(b)(2)(B) (1994). Because of the savings clause, states can
regulate health care coverage to some extent through insurance reform. However, the
deemer clause limits the reach of such reforms by precluding application of insurance
laws to self-insured plans. For a discussion of how the savings clause could be applied
to permit greater regulation of health care coverage concerns, see Karen A. Jordan,
ERISA Pre-emption: Integrating Fabe into the Savings Clause Analysis, 27 RUTGERS L.
J. 273-342 (1996).
58. See generally Jordan, supra note 12. See also Peter D. Jacobson & Scott D.
Pomfret, Form, Function, and Managed Care Torts: Achieving Fairness and Equity in
ERISA Jurisprudence, 35 Hous. L. REV. 985 (1998); Vicki Lawrence MacDougall, The
"Shared Risk" ofPotential Tort Liability ofHealth Maintenance Organizations and the
Defense of ERISA Preemption, 32 VAL. U. L. REV. 855 (1998); Karla S. Bartholomew,
Note, ERISA Preemption ofMedical Malpractice Claims in Managed Care: Asserting
a New Statutory Interpretation, 52 VAND. L. REV. 1131 (1999).
59. FMC Corp. v. Holliday, 498 U.S. 52, 58 (1990); Shaw v. Delta Airlines, Inc.,
463 U.S. 85, 96-97 (1983). See generally Daniel A. Engel, ERISA: Where's the
Preemption Now?, 27 TORT & INS. L. J. 523-54 (1992).
60. FMC Corp., 498 U.S. at 58-59 (limiting the preemption clause to state laws
imposing reporting, disclosure, and fiduciary duties would be incompatible with
Congress's rejection of both House and Senate bills that contained such a limitation).
61. Ingersoll-Rand Co. v. McClendon, 498 U.S. 133, 139 (1990) (citing
Metropolitan Life Ins. Co. v. Massachusetts, 471 U.S. 724, 739 (1985)); Mackey v.
Lanier Collection Agency & Serv., Inc., 486 U.S. 825, 829 (1988) (ERISA preempted
state garnishment statute even though it was enacted to help effectuate ERISA's
underlying purposes).
62. See Shaw, 463 U.S. at 100.
[Vol. 65
18
Missouri Law Review, Vol. 65, Iss. 2 [2000], Art. 2
https://scholarship.law.missouri.edu/mlr/vol65/iss2/2
ERISA PREEMPTION
Travelers Insurance Co.,63 its decisions shed little light on the outer bounds of
the phrase "relates to." 64
Because the phrase "state laws" includes judicial decisions, the Supreme
Court had held, in Pilot Life Insurance Co. v. Dedeaux,6 that ERISA preempts
state common law tort and contract claims arising out of improper processing of
claims for benefits and brought against ERISA plans or their administrators.6
In Pilot Life, the defendant administered the employee disability benefit plan for
Dedeaux's employer. After Dedeaux became disabled in a work-related
accident, Pilot Life Insurance Company approved, terminated, and then
reinstated Dedeaux's disability benefits several times. With little discussion, the
Court held that Dedeaux's state law claims for tortious breach of contract, breach
of fiduciary duties, and fraud "related to" ERISA plans and were preempted.67
However, in assessing whether Dedeaux's claims were exempt from
preemption by the insurance savings clause,6 the Court explained that saving the
state claims would be inconsistent with ERISA Section 502(a) ("§ 502(a)"). 69
Section 502(a) is ERISA's civil enforcement provision. Section 502(a) sets forth
a comprehensive scheme regulating who may bring a civil enforcement action
and the type of actions which may be brought.70 Section 502(a) of ERISA has
come to play a significant role in determining the scope of ERISA preemption
63. 514 U.S. 645 (1995).
64. Only two Supreme Court cases prior to Travelers involved state laws that the
Court held did not "relate to" ERISA plans. See Mackey, 486 U.S. at 833-41 (holding
that ERISA does not bar a state garnishment proceeding against the plan, even though
the proceeding would inflict substantial burdens on the plan administrator because
ERISA prescribes that plans may sue and be sued, but does not prescribe a method for
execution of judgments); Fort Halifax Packing Co. v. Coyne, 482 U.S. 1, 4 (1987)
(holding that ERISA did not preempt a state law requiring employers to provide a one-
time severance payment to employees because, although the law related to benefits, it did
not relate to a "benefit plan").
65. 481 U.S. 41 (1987).
66. See, e.g., Pilot Life, 481 U.S. at 44 (holding that ERISA preempted tort and
contract claims based on allegedly improper processing of a claim for benefits under an
insured plan); Ingersoll-Rand, 498 U.S. at 145 (holding that ERISA preempted a
common law claim for wrongful discharge). At the same time, ERISA contains virtually
no substantive regulation of health or welfare plans, thereby creating a regulatory vacuum
which in reality often fails to protect plan participants and beneficiaries. See generally
William K. Carr & Robert L. Liebross, Wrong Without Rights: The Need for a Strong
Federal Common Law ofERISA, 4 STAN. L. & POL'Y Rnv. 221-29 (1992-93); Norman
Stein, ERISA and the Limits of Equity, 56 LAw & CONTEMP. PROBS. 71-110 (1993).
67. Pilot Life, 481 U.S. at44.
68. See supra note 57.
69. See Pilot Life, 481 U.S. at 57.
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of state common law claims.7 In addition to Pilot Life, other Supreme Court
cases have looked to § 502(a) in determining the scope of ERISA preemption.7"
As in Pilot Life, the Supreme Court has held certain state common law causes
of action preempted when the actions were used to challenge conduct regulated
by ERISA, or to pursue a remedy authorized by ERISA.73 In such cases, the
Court has viewed the state tort or contract action as being inconsistent with
§ 502(a) because the action was being used by the plan participant as an
alternative means of enforcing ERISA.74
After Pilot Life, lower courts readily held that ERISA preempted state law
contract and tort claims brought by plan participants or beneficiaries against
health care providers or plan administrators, or brought by health care providers
against plan administrators.75 Often, preemption was found merely because of
a trickle-down economic effect on ERISA plans. 76 Lower courts could reach that
conclusion only by drawing upon the Supreme Court's generally broad approach
to ERISA preemption. It was in this context that the United States Court of
Appeals for the Fifth Circuit held, in Corcoran v. United Healthcare, Inc., that
71. See, e.g., Dukes v. U.S. Healthcare, Inc., 57 F.3d 350, 354-55 (3d Cir.), cert.
denied, 516 U.S. 1008 (1995). See also infra notes 179-92 and accompanying text.
72. See, e.g., Ingersoll-Rand Co. v. McClendon, 498 U.S. 133, 145 (1990) (holding
that ERISA preempted a Texas common law cause action for wrongful termination to
preclude access to employee benefits because ERISA itself authorizes a civil suit arising
from such a scenario).
73. Id. (holding preempted a Texas common law action for wrongful discharge
arising out of an employer's desire to avoid contributing to or paying benefits under the
employee's pension fund because ERISA regulates such conduct).
74. Accordingly, the Court later explained that such state laws had been found
preempted because the laws constituted an "alternative enforcement mechanism." New
York State Conference of Blue Cross & Blue Shield Plans v. Travelers Ins. Co., 514 U.S.
645, 658 (1995).
75. Various rationales have been used by lower courts in finding that ERISA
preempted state law claims: (1) the claim is really a claim for benefits or a claim for
improper processing of the claim, see, e.g., Corcoran v. United Healthcare, Inc., 965 F.2d
1321, 1332 (5th Cir. 1992); (2) the claim effects plans by causing pass-through costs that
will result in the plan having to choose between higher costs or a reduction in benefits,
see, e.g., Ricci v. Gooberman, 840 F. Supp. 316, 318 (D.N.J. 1993); (3) the claim
regulates the administration of the plan, see, e.g., Dearmas v. Av-Med, Inc., 865 F. Supp.
816, 818 (S.D. Fla. 1994); (4) the claim arises from the provision of benefits pursuant to
an ERISA plan, see, e.g., Dukes v. United States Health Care Sys., Inc., 848 F. Supp. 39,
42-43 (E.D. Pa. 1994), rev'd on other grounds, 57 F.3d 350 (3d Cir.), cert. denied, 516
U.S. 1009 (1995); or (5) the claim requires an examination of plan documents, see, e.g.,
Nealy v. H.S. Healthcare HMO, 844 F. Supp. 966, 972-73 (S.D.N.Y. 1994). In cases
involving contract or tort claims, courts often use several of these rationales. See, e.g.,
Nealy, 844 F. Supp. at 966.
76. See, e.g., Ricci v. Gooberman, 840 F. Supp. 316, 318 (D.N.J. 1993) (finding
preemption because trickle-down economic effect of the law might cause employers to
reduce benefits or to refrain from creating plans).
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ERISA preempts a state law wrongful death action brought to recover damages
arising out of a denial of coverage involving an exercise of medical decision
making.
B. The Corcoran Decision
Corcoran involved a claim by Florence and Wayne Corcoran for damages
resulting from the alleged negligence of a company hired to conduct UR.
Florence obtained her health coverage through a self-funded ERISA benefit plan
which was administered by Blue Cross and Blue Shield of Alabama." The plan
had a UR program that required participants and beneficiaries to obtain pre-
certification for overnight hospital admissions and certain other medical
procedures.78 United Healthcare agreed to perform UR services for Blue Cross.
79
Due to her high risk pregnancy, Florence's obstetrician ordered her
hospitalized as her delivery date neared so that the fetus could be monitored
around the clock. The obstetrician sought pre-certification from United. United
disagreed with the obstetrician's recommendation for hospitalization and instead
authorized ten hours per day of home nursing care. During a period when no
nurse was on duty, the unborn child went into distress and died.80 The Corcorans
brought a wrongful death action against United, alleging that United negligently
denied the medical care recommended by Florence's obstetrician and negligently
determined that home nursing care was adequate for her condition. 8'
The Corcorans argued that their claim was not preempted by ERISA
because they were challenging a medical decision made by United, not merely
an administrative decision about benefit entitlements.82 There was substantial
evidence suggesting that United's contemplated role was to make independent
medical judgments regarding the need for recommended health care. A booklet
provided to plan members explained that the purpose of United's review was to
"assess the need for surgery or hospitalization and to determine the appropriate
length of stay for hospitalization, based on nationally accepted medical
77. Corcoran v. United Healthcare, Inc., 965 F.2d 1321, 1323 (5th Cir.), cert.
denied, 506 U.S. 1033 (1992).
78. Id. The plan used both prospective and concurrent UK. This aspect of the plan
was referred to as the "Quality Care Program." Id.
79. Id.
80. Id.
81. Id. at 1326. The Corcorans also named Blue Cross and Blue Shield as a
defendant, but appealed only the district court's determination that their claim against
United was preempted. Although not clear, this may have been due to a belief that the
claim against Blue Cross was more clearly within the scope of ERISA preemption since
Blue Cross administered the plan. However, under the view of preemption presented in
this Article, the negligent acts of the plan administrator are not shielded from liability for
that reason alone.
82. Id. at 1330.
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guidelines. ' 3 It further noted: "United's staff includes doctors, nurses, and
other medical professionals knowledgeable about the health care delivery
system. Together with your doctor, they work to assure that you and your
covered family members receive the most appropriate medical care." Indeed,
the Fifth Circuit agreed that United made medical decisions."
Nonetheless, the Fifth Circuit held that the Corcorans' action was
preempted by ERISA because the medical decision was made in the context of
a benefits determination under an ERISA plan.
In our view, United makes medical decisions as part and parcel of its
mandate to decide what benefits are available under the [ERISA] plan
.... When United's actions are viewed from this perspective, it
becomes apparent that the Corcorans are attempting to recover for a
tort allegedly committed in the course of handling a benefit
determination. The nature of the benefit determination is different
than the type of decision that was at issue in Pilot Life, but it is a
benefit determination nonetheless. The principle of Pilot Life that
ERISA preempts state-law claims alleging improper handling of
benefit claims is broad enough to cover the cause of action asserted
here.86
Thus, the Fifth Circuit viewed ERISA preemption, as construed in Pilot Life, as
insulating from liability all aspects of any benefit determination.
Notably, the Corcoran court supported its finding of preemption by noting
the financial impact on ERISA plans that might occur if the Corcorans' suit were
allowed to proceed. The court explained that a holding that the action was not
preempted would create a "significant risk that state liability rules would be
applied differently to the conduct of utilization review companies in different
states."87 According to the court, that would in turn cause a financial impact on
83. Id. at 1323 (quoting from a booklet providing a more complete description of
United's Quality Care Program, under the heading: "What QCP Does").
84. Id. at 1324 (quoting from United's Quality Care Program, under a paragraph
headed: "Independent, Professional Review").
85. Id. at 1331. The court stated: "[W]e conclude that United makes medical
decisions-indeed, United gives medical advice ..... " Id. (citing Robert C. Macaulay,
Jr., Health Care Cost Containment and Medical Malpractice: On a Collision Course,
21 SUFFOLK U. L. REv. 91, 106-07 (1986) (noting that an adverse prospective
determination on medical necessity involves "complex medical judgment").
86. Id. at 1332.
87. Id. at 1333. The court apparently viewed possible liability, stating:
It is foreseeable that state courts, exercising their common law powers, might
develop different substantive standards applicable to the same employer
conduct, requiring the tailoring of plans and employer conduct to the
peculiarities of the law of each jurisdiction. Such an outcome is
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ERISA plans: "The cost of complying with varying substantive standards would
increase the cost of providing utilization review services, thereby increasing the
cost to health benefit plans of including cost containment features... (or causing
them to eliminate this sort of cost containment program altogether) and
ultimately decreasing the pool of plan funds available to reimburse
participants.""
The court also expressly rejected the Corcorans' argument that their state
law tort claim involved the regulation of medical decision making, an area
traditionally reserved for state regulation. The court noted: "we [are] 'not
convinced' that the traditional or nontraditional nature of the state law properly
bears upon the initial question whether it is pre-empted by § 514(a), because the
distinction [has] no support in the statutory language. ' 89 Thus, the court gave
little if any weight to the presumption against preemption of state laws involving
the exercise of traditional state authority.
Further, in addition to holding that the Corcorans' state law claims were
preempted, the court rejected the alternative argument that the Corcorans were
entitled to recover damages under § 502(a)(3) of ERISA.9° The court found that
the type of damages the Corcorans sought, money for emotional injuries,91 would
not be available under the trust and contract law principles governing the issue.92
The court, however, was troubled by the prospect of leaving the Corcorans
without a remedy. The court concluded the opinion by noting:
fundamentally at odds with the goal of uniformity that Congress sought to
implement.
Id.
88. Id. Notably, although the court also purported to support its finding of
preemption on the basis of the objectives underlying ERISA preemption, its logic
faltered. The court noted that allowing the suit to proceed would interfere with
Congress's goal of ensuring that plans and plan sponsors would be subject to a uniform
body of law. However, the court quoted a Supreme Court passage that only expressed
concern regarding the imposition of varying state substantive standards on "employer"
conduct-not the conduct of a UR entity providing services for an ERISA plan. Thus,
the preemption holding was supported only by the potential economic impact.
89. Id. at 1334 (citing Sommers Drug Employee Profit Sharing Trust v. Corrigan
Enters., Inc., 793 F.2d 1456, 1468 (5th Cir. 1986), cert. denied, 479 U.S. 1034 (1987)).
90. Id. at 1335. That is, the Corcorans argued in the alternative that if their state
law claims were preempted, they had stated a claim under § 502 of ERISA, ERISA's civil
enforcement provision. Section 502(a)(3) authorizes suits to obtain "other appropriate
equitable relief' to redress violations of, or to enforce, any provisions of ERISA or of the
terms of a plan. See 29 U.S.C. § 1132(a) (1994).
91. Corcoran v. United Healthcare, Inc., 965 F.2d 1321, 1324 (5th Cir.), cert.
denied, 506 U.S. 1033 (1992). The Corcorans sought damages for the lost love, society,
and affection of their unborn child. Additionally, Florence sought damages for the
aggravation of a pre-existing depressive condition and the loss of consortium caused by
the aggravation, and Wayne sought damages for loss of consortium. Id.
92. Id. at 1335.
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While we are confident that the result we have reached is faithful to
Congress' intent neither to allow state-law causes of action that relate
to employee benefit plans nor to provide beneficiaries in the
Corcorans' position with a remedy under ERISA, the world of
employee benefit plans has hardly remained static since 1974.
Fundamental changes such as the widespread institution of utilization
review would seem to warrant a reevaluation of ERISA so that it can
continue to serve its noble purpose of safeguarding the interests of
employees. Our system, of course, allocates this task to Congress, not
the courts, and we acknowledge our role today by interpreting ERISA
in a manner consistent with the express intentions of its creators.93
Thus, the court's harsh stance was grounded in its conviction that, because of the
expansive scope of ERISA preemption, the Corcorans' state law cause of action
was barred. However, that conviction was premised on the court's belief that
(1) Pilot Life mandated preemption of any claim arising from any aspect of the
benefit determination process, (2) allowing the claim to proceed would have a
trickle-down financial effect on ERISA plans caused by increased costs
associated with providing UR, (3) the presumption against preemption was not
applicable in ERISA cases, and (4) any delimitation on the scope of preemption
was solely within the province of Congress.
C. Most Courts Steadfastly Continue to Follow Corcoran
In the years since the Fifth Circuit decided Corcoran, lower courts have
steadfastly followed its reasoning, thereby creating-until very recently-an
impenetrable barrier for ERISA plan participants and beneficiaries who have
been harmed by coverage decisions made by managed care plans. For example,
in Tolton v. American Biodyne, Inc.,94 the Sixth Circuit followed Corcoran and
held that ERISA preempted wrongful death and medical malpractice claims
brought against an HMO that refused to authorize certain psychiatric benefits to
Henry Tolton prior to his suicide because the HMO determined that the
treatment was unnecessary.95 The court, like others, simply viewed Corcoran
as governing the issue. Moreover, lower courts have continued to follow
Corcoran even after recent Supreme Court and courts of appeals decisions
which, as explained in the next section, have greatly undermined Corcoran's
reasoning. For example, in Hull v. Fallon,96 the Eighth Circuit in 1999 followed
Corcoran and held that ERISA preempted a state tort claim against a managed
care plan challenging the plan administrator's decision that a thallium stress test
93. Id. at 1338-39.
94. 48 F.3d 937 (6th Cir. 1995).
95. See 48 F.3d 937 (6th Cir. 1995).
96. 188 F.3d 939 (8th Cir. 1999).
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recommended by the treating physician was not necessary, and authorizing a
treadmill test instead. 97 Other cases reinforce the continued adherence to
Corcoran.
98
Unfortunately, many courts have elected to follow Corcoran without
independent analysis of the continued soundness of the reasoning used by the
Corcoran court. One exception is the decision in Corporate Health Insurance
Inc. v. Texas Department of Insurance,99 in which a federal district court held
that ERISA does not preempt a Texas legislative provision that authorizes civil
suits against managed care entities. The managed care entities' strongest
argument supporting preemption was the fact that the civil action authorized by
the statute constituted a state common law suit akin to the suit in Corcoran,
thereby warranting preemption. The court in Corporate Health expressly opined
that, if decided today, Corcoran would "perhaps be decided differently."'0°
Nonetheless, the court felt compelled to remain consistent with Corcoran and
thus construed the Texas provision as authorizing a suit distinguishable from that
at issue in Corcoran'01
97. Id. at 943; see also Thompson v. Gencare Health Sys., Inc., 202 F.3d 1072 (8th
Cir. 2000).
98. See, e.g., Parrino v. FHP, Inc., 146 F.3d 699, 704-05 (9th Cir. 1998) (holding
preempted state law claims arising from a managed care entity's alleged wrongful initial
denial of coverage for proton beam therapy upon a UR finding that the treatment was
experimental and unnecessary); Turner v. Fallon Community Health Plan, 127 F.3d 196,
200 (1st Cir. 1997) (holding preempted a state law claim that a managed care entity
wrongfully denied coverage for a type of bone marrow transplant and high dose
chemotherapy treatment (although this case may not have given rise to a tort claim));
Huss v. Green Spring Health Servs., 18 F. Supp. 2d 400, 405 (D. Del. 1998) (holding
preempted a state tort claim that a managed care plan negligently failed to verify
coverage and refused to cover treatment for a psychiatric disorder); Benoit v. Grainger,
Inc., No. 98-1315, 1998 WL 749444, at *3 (E.D. La. Oct. 21, 1998) (holding preempted
a medical malpractice claim against an HMO challenging the HMO's allegedly negligent
initial decision not to authorize immediate surgery for the plaintiff following a
motorcycle accident); Andrews-Clarke v. Travelers Ins. Co., 984 F. Supp. 49, 54-55 (D.
Mass. 1997) (holding preempted claims that a managed care entity repeatedly and
negligently refused to authorize inpatient rehabilitation and detoxification treatment).
99. 12 F. Supp. 2d 597 (S.D. Tex. 1998).
100. Id. at 617.
101. Id. The Texas provision authorizes individuals to sue managed care entities
for damages proximately caused by the entity's failure to exercise ordinary care when
making a health care treatment decision. Id. at 602. The statute defines "health care
treatment decision" as "a determination made when medical services are actually
provided by the health care plan and a decision which affects the quality of the diagnosis,
care, or treatment provided to the plan's insureds or enrollees." Id. at 617 (quoting TEX.
Civ. PRAc. & REM. CODE ANN. § 88.001(5) (West 1998)). The court in Corporate
Health construed the Act as authorizing a suit challenging the "quality" of medical care
received (e.g., a direct or vicarious claim arising from provider malpractice); and thus as
authorizing a suit distinguishable from a Corcoran-type claim which arises because
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Even courts that strongly believe that the result in Corcoran was
unjustifiably inequitable have felt constrained to follow Corcoran. InAndrews-
Clarke v. Travelers Insurance Co.,102 Judge Young of the United States District
Court for the District of Massachusetts made an impassioned plea for
congressional attention to the problem of ERISA preemption. 3 The case
involved a managed care entity's repeated denials of coverage for inpatient
rehabilitation and detoxification treatment for an individual covered by an
ERISA plan. The court noted
[Clarke's] policy expressly provided coverage for certain medical and
psychiatric treatments, including enrollment in a thirty-day inpatient
alcohol detoxification and rehabilitation program. Doctors at several
hospitals, and even the courts of the Commonwealth of Massachusetts,
determined that Clarke was in need of such treatment, but the insurer
and its agent, the utilization review provider, repeatedly and arbitrarily
refused to authorize it.'
The plaintiff's suit included, among other claims, a negligence claim challenging
the managed care plan's "failure to diagnose the severity of Clarke's condition
coverage for recommended medical care has been denied and the patient is injured as a
consequence of not receiving the recommended care.
102. 984 F. Supp 49 (D. Mass. 1997).
103. Judge Young stated: "Under any criterion... the shield of near absolute
immunity now provided by ERISA simply cannot be justified." Id. at 63. Judge Young
also stated:
A more efficient approach is to allow insurers and utilization review providers
to make benefit determination on a case-by-case basis, but hold them legally
accountable for the consequences of their decisions. By ensuring that bad
medical judgments made during the utilization review process do not 'end up
being cost-free to the plans that rely on [UR] to contain medical costs,' plan
administrators will have more incentive to 'seek out those [UR providers] that
can deliver both high quality services and reasonable prices.'
Id. at 62. Judge Young further stated:
Unfortunately, to date, 'ERISA [has proven] an excellent example of the
classic observation that it is a great deal more difficult for Congress to correct
flawed statutes than it is to enact them in the first place.., because interests
coalesce around the advantageous aspects of the status quo.' Although the
alleged conduct of Travelers and Greenspring in this case is extraordinarily
troubling, even more disturbing to this Court is the failure of Congress to
amend a statute that, due to the changing realities of the modem health care




104. Id. at 52.
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during the utilization review process."' 5 Despite the judge's deep conviction
that preemption was unjust, the court nonetheless followed Corcoran and held
the claims preempted because the claims-including the malpractice claim---"go
right to the heart of the benefit determination process.""°
Importantly, and despite the definite tendency of lower courts to continue
following Corcoran's rationale, at least one federal court has moved in the
opposite direction due to recent Supreme Court and courts of appeals decisions
which arguably narrow the scope of preemption. In Moscovitch v. Danbury
Hospital,0 7 state law claims were brought against Physician Health Services
("PHS"), the entity that administered the group medical plan covering the
plaintiff's son. PHS first authorized admission for the plaintiff's son to Danbury
Hospital after two suicide attempts; but seven days later terminated the inpatient
coverage and required the child to be transferred to Vitam Center, an allegedly
inappropriate facility because Vitam was only prepared to treat adolescents with
substance abuse problems.108 The plaintiff's son committed suicide on the day
of the transfer. The plaintiffs complaint included direct and vicarious tort
claims against PHS.1 9 In finding that ERISA did not preempt the claims, the
court focused on the fact that the claims challenged the appropriateness of the
medical and psychiatric decisions of PHS. The court noted: "[The claim] does
not assert that PHS was making wrong decisions about whether certain care
would be covered by its plan, but instead challenges the decision made by PHS
with respect to the quality and appropriate level of care and treatment for the
decedent."" 0° Thus, although the claim at issue clearly also could have been
characterized as arising from the denial of further coverage for inpatient hospital
care, the court decided that the fact that the claim challenged a medical care
decision pulled it outside the reach of ERISA preemption."'
The Moscovitch case clearly raises the question whether, in light of more
recent precedent, ERISA preemption should continue to be extended to cases
105. Id. at 56 n.23.
106. Id. at 58 ("As all of her common law claims arise out of denial of benefits
under an ERISA plan, they fall squarely within the scope of ERISA's civil enforcement
provision, section 502(a) .... ).
107. 25 F. Supp. 2d 74 (D. Conn. 1998); see also infra notes 207-09 and
accompanying text (discussing further the analysis used in this decision).
108. Id. at 76. Claims were also brought against Danbury Hospital and Vitam
Center, Inc.
109. Id. The claims against PHS in the plaintiffs original complaint were
grounded in state statutory provisions. The plaintiff amended the complaint to include,
against PHS, only state common law tort theories grounded in direct and vicarious
liability. Id. at 77.
110. Id. at 80. The court pointed to allegations that PHS failed to properly
diagnose and assess the decedent's psychiatric condition, failed to properly monitor, care,
and treat him, and failed to properly oversee his treatment. Id.
111. Id. at 81-82.
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arising from denials based on determinations of medical necessity. If this view
of ERISA preemption is valid, the courthouse door will be opened to at least
some lawsuits that arise from coverage denials that result in harm, thereby
raising the issue of whether a federal amendment to ERISA allowing suits
against managed care plans is necessary. Accordingly, the issues to be
considered are (1) whether the approach to preemption used by the court in
Moscovitch is sound and (2) if so, to what extent does that approach to
preemption eviscerate the preemption problem for ERISA plan participants and
beneficiaries. Before addressing those issues, however, it is useful to understand
the basics of the federal provisions passed by the House.
IV. THE FEDERAL LEGISLATIVE SOLUTION:
THE NORWOOD-DINGELL PROVISIONS
On October 7, 1999, the House passed a managed care reform bill
sponsored by Representatives Charlie Norwood (R-Ga.) and John Dingell (D-
Mich.).u2 The Norwood-Dingell bill includes provisions that would exempt
from ERISA preemption state law claims against managed care plans by patients
injured by denials of or delays in medical care. The Norwood-Dingell bill was
selected over three other bills that emerged in the final weeks before the House
vote.'13 Those bills also contained provisions allowing suits against managed
care plans, but would have limited the scope of claims allowed." 4 In contrast,
the Norwood-Dingell provisions are notable for their breadth, although they
include some restrictions which are described in the following paragraphs. The
Norwood-Dingell bill amends § 514 of ERISA by adding a subsection which
states that:
[N]othing in this title shall be construed to invalidate, impair, or
supersede any cause of action by a participant or beneficiary... under
State law to recover damages resulting from personal injury or for
wrongful death against any person-(i) in connection with the
provision of insurance, administrative services, or medical services by
112. See H.R. 2723, 106th Cong. (1999). The bill is titled "Bipartisan Consensus
Managed Care Improvement Act of 1999." H.R. 2723 § 1(a). After passage of the
Norwood-Dingell bill, the House passed a Republican package of tax breaks and
insurance reforms designed to increase access to health care coverage. Following that
vote, the Norwood-Dingell bill was merged with the access bill. The combined bill kept
the bill number of the access measure. See GOP Leaders Fail to Name Norwood, supra
note 9, at d3.
113. Alternative bills were offered by Tom Coburn (R-Okla.) and John Shadegg
(R-Ariz), H.R. 2824, 106th Cong. (1999) (the Cobum-Shadegg bill); by Amo Houghton
(R-N.Y.), H.A. 515, 106th Cong. (1999); and by John Boehner (R-Ohio), H.R. 2926,
H.R. 2089, 106th Cong. (1999).
114. See infra notes 121-24 and accompanying text.
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such person to or for a group health plan, or (ii) that arises out of the
arrangement by such person for the provision of such insurance,
administrative services, or medical services by other persons."'
Thus, the bill does not attempt to delimit in any way the types of state law claims
that are exempt from preemption, or the type of conduct that could give rise to
a claim. 1 6 An action could arise from any aspect of a managed care plan's
operation, e.g., providing health insurance benefits, administering health benefit
plans, providing medical services pursuant to a plan, or arranging any of these
services. Further, by authorizing suits against "any person," any managed care
plan or UR entity could be held liable, regardless of its organizational structure,
as long as the plan provides services for an ERISA plan.
117
Therefore, the liability provisions in the Norwood-Dingell bill would
eliminate, in part, the preemption problem posed by Corcoran. As explained,
courts have steadfastly followed Corcoran's view that any claim intertwined
with a benefit determination is preempted."' The Norwood-Dingell bill would
represent an explicit statement by Congress that ERISA does not preempt suits
arising from coverage denials that result in personal injury or wrongful death.
Moreover, the Norwood-Dingell bill would do more than eviscerate the impact
of Corcoran. All suits arising from coverage denials would be free from the
constraints of ERISA preemption-not just those involving an exercise of
medical judgment. Thus, state law actions arising from both categories of
coverage denials would be permitted, and claims akin to those in the Johnson
and Goodrich cases could be brought by ERISA plan participants and
beneficiaries.
At the same time, the preemption problem is only partially eliminated
because the Norwood-Dingell bill contains a significant restriction on the
availability of punitive damages. The bill provides that the plan would not be
115. See H.R. 2723 § 302(a) (amending § 514 of ERISA by adding
§ 514(e)(1)(A)(i)-(ii)).
116. Further, House Bill 2723 would not require ERISA plan participants and
beneficiaries to exhaust the plan's administrative process where the injury or death
occurred before completion of the process. H.R. 2723 § 302(a) (amending § 514 of
ERISA by adding § 514(e)(3)).
117. The provision uses the definition of group health plan established-in the
Health Insurance Portability and Accountability Act of 1996 ("HIPAA"). HIPAA defines
group health plan as an employee welfare benefit plan to the extent the plan provides
medical care to employees or their dependents directly or through insurance,
reimbursement, or otherwise. See 29 U.S.C. § 1191b(a)(1) (Supp. III 1997). The bill
appropriately notes that the provision generally does not authorize any cause of action
or any right of indemnity against "an employer or other plan sponsor maintaining the
group health plan (or against an employee of such employer)." H.R. 2723 § 302(a)
(amending § 514 of ERISA by adding § 514(e)(2)(B)(i)-(ii)); see also infra note 234 and
accompanying text.
118. See supra notes 94-106 and accompanying text.
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liable for punitive damages if the claim relates to an "externally appealable
decision"; the external appeal was initiated in a timely manner and completed;
and the plan complied with the determination resulting from the external
appeal."' Under the bill, an "externally appealable decision" is a coverage
denial arising from conduct involving an exercise of medical judgment. 20 Thus,
although ERISA plan participants and beneficiaries with claims akin to those in
the Johnson and Goodrich cases could bring suit, they would be limited to
compensatory damages.
Whether the Norwood-Dingell bill has struck the right balance as a matter
of health policy is explored in Part VI of this Article. As noted, other bills
advanced in the House would have restricted even further the liability of
managed care plans. One bill would have allowed suits against managed care
plans only upon a showing of "substantial harm," and would have restricted
punitive damages to cases where the managed care plan showed "conscious,
flagrant indifference to the rights or safety of others.'' Further, the bill would
have limited noneconomic damages to the lesser of $500,000 or twice the
economic damages, while punitive damages would have been capped at the
greater of $250,000 or twice the economic damages."2 The bill also would have
imposed court costs on the plan participant or beneficiary if an external review
board ruled that the patient was not actually injured and the patient sued
anyway.' Another bill would have allowed lawsuits only against the person
making the "sole final decision" to deny care and would have banned punitive
damaged altogether if the plan's denial of coverage was upheld by the external
reviewers.124
Because the Norwood-Dingell bill passed by a substantial margin, despite
the availability of more limited liability options, it might seem as though the
House membership broadly supports substantially curtailing the scope of ERISA
preemption with regard to state common law claims against managed care plans.
In reality, the future of the bill is uncertain for two key reasons. First, the
Norwood-Dingell bill never won the support of House leadership, and thus
119. H.R. 2723 § 302(a) (amending § 514 of ERISA by adding § 514(e)(1)(B)(i)-
(iv)).
120. The term is defined as:
[A] denial of claim for benefits ... (i) that is based in whole or in part on a
decision that the item or service is not medically necessary or appropriate or
is investigational or experimental; or (ii) in which the decision as to whether
a benefit is covered involves a medical judgment.
H.R. 2723 § 103(a)(2).
121. See Plan Regulation: Norwood-Dingell Managed Care Bill Sails Through
House in Massive Bipartisan Vote, HEALTH CARE DAILY (BNA), Oct. 8, 1999, at d2,
available in WL 10/8/1999 HCD d2 (describing the Cobum-Shadegg bill).
122. Id.
123. Id.
124. Id. (describing the Houghton amendment).
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conference committee members from the House may not fight to save the
provision.1" Second, the managed care legislation passed in the Senate does not
expand a patient's right to sue a plan, and the Senate legislation is significantly
different in other respects as well.126 Predictions of difficult negotiations make
it far from clear that the House provision will survive the conference committee
process.'2 Accordingly, as noted in Part I, while one purpose of this Article is
to contribute to the debate regarding the need for a federal amendment to
ERISA, another purpose is to provide guidance to courts and litigants regarding
the proper preemption analysis in the event the House bill does not survive the
conference process.
V. GIvEN THE EMERGING VIEW OF PREEMPTION, Is FEDERAL
LEGISLATION NECESSARY?
The House provision addresses the problem posed by Corcoran, namely the
preemption of all state law claims, by ERISA plan participants or beneficiaries,
against a managed care plan arising out of a denial of coverage. However,
federal legislation may not be necessary if the approach used by the court in
Moscovitch is sound. Subparts V(A) and V(B) therefore assess the soundness
of arguments that recent precedent has greatly undermined the reasoning used
by the Fifth Circuit in Corcoran. The analysis concludes that'the Moscovitch
approach is sound. But the analysis does not end there. Even if the Moscovitch
approach is sound, it is essential to analyze the extent to which the emerging
view of preemption will allow courts to deviate from Corcoran and, ultimately,
whether a federal amendment to ERISA is unnecessary. That is, the analysis
must also consider whether Corcoran's obstacle can be completely eviscerated
or whether some state law claims against managed care plans will remain barred
notwithstanding a narrower approach to preemption. The analysis shows that
some claims arising from a coverage denial would remain preempted and, thus,
a federal legislative solution may be preferable to the judicial solution.
A. The Supreme Court Trilogy
Since 1995, the Supreme Court has decided several cases that have caused
lower courts to approach the ERISA preemption analysis differently than when
125. Indeed, only one of the 13 Republican conferees actually voted for the
Norwood-Dingell bill, although 68 Republicans in the House defied their leadership and
voted for the bill. Interestingly, the House approved a motion to instruct the House
conferees to "insist" on the Norwood-Dingell liability provisions during the conference
with the Senate. However, the instruction is advisory only and thus is not binding on the
conferees. See GOP Leaders Fail to Name Norwood, supra note 9, at d3.
126. See S. 1344, 106th Cong. (1999).
127. See Norwood-Dingell Managed Care Bill, supra note 121, at d2.
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Corcoran was decided. Three cases are particularly noteworthy: New York
State Conference ofBlue Cross & Blue Shield Plans v. Travelers Insurance Co.,
California Division ofLabor Standards Enforcement v. Dillingham Construction
Inc., and DeBuono v. NYS-ILA Medical & Clinical Services Fund.'28 This
trilogy of cases has prompted lower courts to take a more pragmatic or purposive
approach to preemption, rather than simply viewing the language of§ 514(a) as
broadly preempting any state law with any "relation to" ERISA plans. The
result has been a narrowing of the range of state laws that should be found to be
within the scope of ERISA preemption.
1. The Narrowing of § 514(a) Preemption
The most significant case in the Supreme Court trilogy is New York State
Conference of Blue Cross & Blue Shield v. Travelers Insurance Co.
Travelers.12 9 Travelers addressed preemption of New York's inpatient hospital
rate-setting system."30 In upholding the state law, the Court shed substantial light
on several aspects of the preemption analysis."' Foremost, the Court in
Travelers stressed what lower courts had increasingly overlooked-that the
resolution of preemption claims must be premised on a presumption against
preemption, especially in cases where federal law would be supplanting state
action in a field of traditional state regulation.'
128. New York State Conference of Blue Cross & Blue Shield Plans v. Travelers
Ins. Co., 514 U.S. 645 (1995); California Div. of Labor Standards Enforcement v.
Dillingham Constr. Inc., 519 U.S. 316 (1997); DeBuono v. NYS-ILA Med. & Clinical
Servs. Fund, 520 U.S. 806 (1997). Another important case is Boggs v. Boggs, 520 U.S.
833 (1997). See infra note 136 and accompanying text (discussing Boggs).
129. 514 U.S. 645 (1995).
130. New York's rate-setting system establishes the rates that hospitals may charge
various payers. Payers are categorized into three groups. The first group, including the
state as payer for Medicaid, Blue Cross and Blue Shield plans, and HMOs, may be
charged only a base "diagnostic-related" rate ("the DRG rate"). The second group,
including some self-insured plans and commercial insurers, may be charged the DRG rate
plus a 13% surcharge. The third group consisting of all other payers may be charged
actual hospital charges up to a statutory limit of 120% of the rate charged payers in group
two. See N.Y. PuBLIc HEALTH LAW § 2807-c (McKinney 1994).
131. For a more detailed discussion of a broad interpretation of the Court's opinion
in Travelers, see Jordan, supra note 12, at 255. For other perspectives of the Travelers
decision, see generally Catherine L. Fisk, The LastArticle About the Language of ERISA
Preemption? A Case Study of the Failure of Textualism, 33 HARV. J. ON LEGIS. 35
(1996); Paul J. Ondrasik, New York State Conference of Blue Cross & Blue Shield Plans
v. Travelers Ins. Co.-Back to the Future?, ERISA LMIG. REP., Fall 1995, at 4.
132. Travelers, 514 U.S. at 655. In Travelers, the Court noted:
[I]n cases like this one, where federal law is said to bar state action in fields
of traditional state regulation, we have worked on the "assumption that the
historic police powers of the States were not to be superceded by the Federal
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The Court also moved away from its open-ended view of the scope of
ERISA preemption. The Court noted that, although the "relates to" language of
the preemption clause is clearly expansive, its meaning must be limited."' The
Court then observed that its previously established standard for analyzing
preemption-whether the law has a "connection with or reference to" an ERISA
plan-was, without more guidance, similarly unhelpful.13 The Court stated:
"We simply must go beyond the unhelpful text and the frustrating difficulty of
defining its key term, and look instead to the objectives of the ERISA statute as
a guide to the scope of the state law that Congress understood would survive."'35
The Court thus, in essence, suggested that ERISA preemption analysis should
resemble implied preemption analysis.
136
Additionally, the Court provided a benchmark for determining when state
laws frustrate congressional purposes. The Court looked to legislative history
and found that the "basic thrust of the pre-emption clause was to avoid a
multiplicity of regulation in order to permit the nationally uniform administration
of employee benefit plans.', 137 Then, after reviewing its prior cases, the Court
concluded that laws it had found preempted due to a connection with ERISA
plans were laws that either mandated employee benefit structures or
administrative practices of ERISA plans13 or constituted alternative enforcement
mechanisms. 39 The Court's holding that the New York rate-setting provisions
were not preempted hinged on the fact that the system caused only an "indirect
economic influence" on protected ERISA plans that did "not bind plan
Act unless that was the clear and manifest purpose of Congress."
Id. (citations omitted).
133. Id. The Court stated that "if 'relate to' were taken to extend to the furthest
stretch of its indeterminancy, then for all practical purposes pre-emption would never run
its course, for '[r]eally, universally, relations stop nowhere."' Id. (quoting H. JAMEs,
RODERICK HuDsoN xli (New York ed., World's Classics 1980).
134. Id. at 656 (noting that "[flor the same reasons that infinite relations cannot be
the measure of pre-emption, neither can infinite connections"). The Court did not
elaborate on the "reference to" prong of the test because the Court found that New York's
rate-setting legislation did not reference ERISA plans at all. Id. But see District of
Columbia v. Greater Washington Bd. of Trade, 506 U.S. 125 (1992).
135. New York State Conference of Blue Cross & Blue Shield Plans v. Travelers
Ins. Co., 514 U.S. 645, 656 (1995).
136. Accord Boggs v. Boggs, 520 U.S. 833 (1997). In Boggs, the Supreme Court
used an implied preemption analysis. This was significant because, prior to Boggs, the
Court had appeared to follow an express preemption analysis-albeit one that looked
beyond the text of the preemption provision. See generally Karen A. Jordan, The Shifting
Preemption Paradigm: Conceptual and Interpretive Issues, 51 VAND. L. REV. 1149
(1998).
137. Travelers, 514 U.S. at 657.
138. See, e.g., Shaw v. Delta Airlines, Inc., 463 U.S. 85 (1983).
139. See, e.g., Ingersoll-Rand Co. v. McClendon, 498 U.S. 133 (1990); Pilot Life
Ins. Co. v. Dedeaux, 481 U.S. 41 (1987).
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administrators to any particular choice and thus function as a regulation of an
ERISA plan itself.' 140
Lastly, and most significantly for purposes of this Article, the Court
implied that it was clear that it would frustrate congressional purposes to find
that ERISA preempts state laws regulating the quality of health care. In
observing how unlikely it was that Congress intended ERISA to preempt the
rate-setting provisions at issue, the Court explained:
Quality standards, for example, set by the State in one subject area of
hospital services but not another would affect the relative cost of
providing those services over others and, so, of providing different
packages of health insurance benefits. . . . Quality control . . .
regulation, to be sure, [is] presumably less likely to affect premium
differentials among competing insurers, but that does not change the
fact that such state regulation will indirectly affect what an ERISA or
other plan can afford or get for its money. Thus, in the absence of a
more exact guide to intended pre-emption than § 514, it is fair to
conclude that mandates for rate differentials would not be pre-empted
unless other regulation with indirect effects on plan costs would be
superseded as well. 4 '
Thus, the decision readily can be construed as supporting the view that Congress
did not intend for ERISA to preempt state laws regulating the quality of health
care.
The Supreme Court affirmed Travelers's more restrictive view of when a
state law has a sufficient "connection with" an ERISA plan to warrant
preemption in the other two cases in the trilogy: 42 California Division ofLabor
Standards Enforcement v. Dillingham Construction, N.A., Inc.,143 and DeBuono
140. Travelers, 514 U.S. at 659-60. The Court further explained that the system:
[S]imply bears on the costs of benefits and the relative costs of competing
insurance to provide them. It is an influence that can affect a plan's shopping
decisions, but it does not affect the fact that any plan will shop for the best
deal it can get, surcharges or no surcharges.
Id. at 660.
141. Id. at 660-61.
142. When a state law conflicts with an ERISA provision, the conflict alone is
sufficient to warrant preemption. See, e.g., Boggs v. Boggs, 520 U.S. 833 (1997). This
would be true under traditional preemption doctrine even absent ERISA's specific
preemption provisions.
143. 519 U.S. 316 (1997). In Dillingham, the Court upheld California's prevailing
wage law, which permits contractors to pay a lower wage for workers participating in
approved apprenticeship programs. As in Travelers, the prevailing wage law regulated
an area traditionally governed by states and was consistent with federal law. But the key
to the analysis was the Court's finding that the state law "does not bind ERISA plans to
anything." Id. at 332. Rather, the Court found that the law merely provides an econoni
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v. NYS-ILA Medical & Clinical Services Fund.44 At issue in DeBuono was a
New York tax on gross receipts for patient services imposed on certain health
care entities. The law was challenged by a self-funded ERISA plan which
owned and operated medical clinics on which the tax was imposed. The Court
held that although New York's provider tax affected plans that own and operate
medical centers more directly, the law nonetheless merely caused an increase in
costs, which influences choices made by employers or plan administrators.
141
Thus, whether direct or indirect, a mere economic effect on ERISA plans is
insufficient to trigger preemption.1
46
The trilogy of Supreme Court cases, then, has established a more pragmatic
or purposive approach to preemption, rather than an approach that simply views
the language of § 514(a) as broadly preempting any state law with any
"reference to or association with" ERISA plans. More specifically, the cases re-
established the relevance of a strong presumption against preemption in an
analysis involving a state law in an area of traditional state regulation, and they
established that ERISA preemption analysis is akin to implied preemption
analysis, which hinges on frustration of congressional purpose. At the same
time, the Court did not displace its largely categorical approach to preemption.
The test is still whether a state law has an impermissible connection with or
incentive to encourage employers or plan sponsors to set up apprentice programs that
comport with state requirements. Id. at 333-34. Thus, the Court's approach in
Dillingham confirmed Travelers's more restrictive standard for determining whether a
state law is preempted because of its effect on ERISA plans. Characteristically, lower
court decisions since Travelers have not interpreted the decision uniformly. Compare
NYS Health Maintenance Org. Conference v. Curiale, 64 F.3d 794 (2d Cir. 1995)
(upholding a state law requiring HMOs to engage in open enrollment and community
rating by applying Travelers's restrictive standard), with Boyle v. Anderson, 68 F.3d
1093 (8th Cir. 1995) (upholding a two percent provider tax, but applying Travelers very
narrowly).
144. 520 U.S. 806 (1997).
145. Id. at 815-16. The Court stated:
If the Fund had made the other choice, and had purchased health care services
from a hospital, that facility would have passed the expense of the [tax] onto
the Fund and its plan beneficiaries through the rates it set for the services
provided. The Fund would then have had to decide whether to cover a more
limited range of services for its beneficiaries, or perhaps to charge plan
members higher rates. Although the tax in such a circumstance would be
"indirect," its impact on the Fund's decisions would be in all relevant respects
identical to the "direct" impact felt here.
Id. at 816.
146. Notably, the Court qualified its holding in Travelers by acknowledging that
"a state law might produce such acute, albeit indirect, economic effects, by intent or
otherwise, as to force an ERISA plan to adopt a certain scheme of substantive coverage
or effectively restrict its choice of insurers, and that such a state law might indeed be pre-
empted under § 514." New York State Conference of Blue Cross & Blue Shield Plans
v. Travelers Ins. Co., 514 U.S. 645, 668 (1995).
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reference to ERISA plans. But the Court has provided two specific benchmarks
for when a state law's effect on ERISA plans frustrates congressional purposes:
(1) an economic effect on ERISA plans, whether direct or indirect, is generally
insufficient to trigger preemption; and (2) the effect on ERISA plans of state
laws regulating the quality of health care is generally insufficient to trigger
preemption. The result therefore has been a narrowing of the range of state laws
that should be found to be within the scope of§ 514(a).
2. The Trilogy Significantly Undermines Corcoran-The Implied
Preemption Analysis
The modifications to the preemption analysis suggested by the trilogy of
Supreme Court cases have greatly undermined the Corcoran approach. As
noted, the Corcoran holding was premised on the Fifth Circuit's belief that
(1) Pilot Life mandated preemption of any claim arising from any aspect of the
benefit determination process, (2) allowing the claim to proceed would have a
trickle down financial effect on ERISA plans caused by any increased costs
associated with providing UR, (3) the presumption against preemption was not
applicable in ERISA cases, and (4) any delimitation on the scope of preemption
was solely within the province of Congress. 47
Several points made by the Supreme Court in the trilogy are directly
inconsistent with the Fifth Circuit's premises. First, the court in Corcoran
specifically opined that the traditional or nontraditional nature of the state law
did not bear on the preemption issue. This aspect of Corcoran is undermined by
the Supreme Court's recognition of the strong presumption against preemption
of state laws in a field of traditional state regulation. Second, the Corcoran court
supported its holding of preemption by pointing to the trickle-down economic
effect that might result from imposing tort liability on entities that perform UR
for ERISA plans. Yet the Supreme Court trilogy holds that an economic effect
on an ERISA plan, whether direct or indirect, is generally insufficient to trigger
preemption. Third, the Supreme Court's shift to a pragmatic or purposive
approach to preemption reflects a recognition that delimitation of the scope of
preemption is not solely within the province of Congress, as believed by the
Fifth Circuit. A purposive approach to statutory interpretation is premised on the
judiciary's involvement in the lawmaking process.'48 Fourth, the Corcorans'
147. See supra note 93 and accompanying text.
148. See, e.g., Jordan, supra note 136, at 1202-05, & 1219-20 (explaining, in part,
that a purposive approach to statutory interpretation views the judiciary's role as one of
effectuating the purpose embodied in legislation; thus, a court using a purposive
approach to interpretation puts itself in the place of a reasonable legislature, strives to
ascertain the underlying reason for the provision, looks beyond the text of the statue to
the context of its enactment when necessary, and interprets the statute in a way that best
harmonizes fundamental policies and fits the provision into the general fabric of the law).
See also Jordan, supra note 136, at 1210 n.285 (listing of useful law review articles
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claim constituted an attempt to hold the UR entity accountable for a negligent
medical decision and therefore constituted a state law regulating the quality of
health care. Thus, the Corcoran court's view that its holding was mandated by
Pilot Life is undermined by the Supreme Court's strong implication that the
effect on ERISA plans of state laws regulating the quality of health care is
generally insufficient to trigger preemption.149 A tort suit challenging an
allegedly negligent medical decision is, of course, distinguishable from the types
of "quality-control" regulation explicitly referred to in Travelers.15° But the
logic of the Travelers opinion suggests that these suits are sufficiently analogous
to warrant similar treatment.
More fundamentally, the Supreme Court in Travelers signaled that the
ERISA preemption analysis is akin to an implied preemption analysis, and
implied preemption analysis supports the view that a tort suit challenging an
allegedly negligent medical decision is not preempted. Implied preemptior
analysis turns on whether the state law at issues frustrates congressional
purposes.' Allowing a claim challenging an allegedly negligent medical
determination would not frustrate congressional purposes.1 52 In enacting ERISA
and its preemption provisions, Congress sought to balance several interests: the
protection of employees and their rights to benefits, the formation and
maintenance of employee benefit plans, and the avoidance of a multiplicity of
state laws that would prevent employers from operating interstate benefit
plans.15 As the following analysis shows, allowing negligence suits to proceed
addressing statutory interpretation).
149. Notably, the federal district court in Corporate Health Ins. Inc. v. Texas Dep "t
of Ins., 12 F. Supp. 2d 597 (S.D. Tex. 1998), reached the same conclusion. The court
noted: "In light of the Supreme Court's recent mandate regarding ERISA preemption
analysis, perhaps the Fifth Circuit would reach a different decision in Corcoran today."
Id. at 617. However, as noted supra note 101, the court avoided the issue by construing
the relevant Texas liability provision as reaching conduct distinguishable from the
conduct at issue in Corcoran. Corporate Health, 12 F. Supp. 2d at 617.
150. The Court in Travelers noted:
Quality standards, for example, set by the State in one subject area of hospital
services but not another would affect the relative costs of providing those
services over others and, so, of providing different packages of health
insurance benefits. Even basic regulation of employment conditions will
invariably affect the costs and price of services.
Travelers, 514 U.S. at 660-61.
151. For a greater discussion of the nature of the implied preemption analyses, see
Jordan, supra note 136, at 1165-76.
152. See Fort Halifax Packing Co. v. Coyne, 482 U.S. 1 (1987).
153. See ROSENBLATr ETAL., supra note 17, at 195-96 (providing an overview of
the genesis of ERISA). In addition to being concerned with the difficulties faced by
employers wanting to establish benefit plans for employees in several states, Congress
also was concerned with the employer practice of underfunding pension plans and with
plan administrators who regularly breached fiduciary obligations. See ROSENBLATT ET
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against managed care plans would not disrupt the balance established by
Congress.
a. A Corcoran-Type Claim Would Not Infiinge on Employer Interests
A tort suit against a managed care plan challenging a negligent medical
decision would only indirectly and insubstantially affect ERISA plans or
employers operating ERISA plans, and thus would not overly burden employer
interests. Understanding this point requires an understanding of the structure of
ERISA plans, and how coverage decisions generally are made. Private
employers may establish health plans in several different ways. Sponsors of
smaller plans generally choose not to underwrite the risk of health care and
instead purchase coverage for plan participants. These employers contract with
a traditional insurance company, a health care service corporation such as a Blue
Cross or Blue Shield company, a preferred provider organization ("PPO"), a
health maintenance organization ("HMO"), or any other entity licensed to bear
risk.'54 ERISA plans created through such arrangements are referred to as
"insured" ERISA plans because the risk of the participants' health care expenses
is borne by the entity with whom the employer contracts. In contrast, sponsors
of larger health plans generally choose to be "self-insured" in whole or in part.'55
As the label implies, employers who self-insure elect to assume the risk of health
care expenses themselves. 56
AL., supra note 17, at 195-96.
154. See Clifford A. Cantor, Fiduciary Liability in Emerging Health Care, 9
DEPAULBUS. L.J. 189, 194 (1997).
155.' See Cantor, supra note 154, at 195 nn.23-24 (noting that in 1994 74% of
employers with 500 employees or more self-insured their health plans) (citing Group
Health Care Covers Most Americans, Takes Larger Piece of Compensation Pie, HEALTH
CARE DAILY (BNA), Aug. 29, 1995, at d2); G. Jensen et al., The New Dominance of
Managed Care: Insurance Trends in the 1990s, 15 HEALTH AFFAIRS 125 (1997) (noting
that 46% of employees were covered by self-insured health plans in 1995); Number of
Self-Insured Plans Declines Due to Rise in Managed Care, Study Says, HEALTH CARE
DAILY (BNA), Aug. 9, 1996, at d8 (noting that 51% of employees were covered by self-
insured plans in 1995). The prevalence of self-insured plans is due to the cost savings
which inure to the employer by not paying another party to accept underwriting risk,
through lower administrative costs, and due to exemption from state insurance regulation
pursuant to ERISA's deemer clause.
156. However, all but the largest employers purchase some level of reinsurance or
stop-loss insurance to protect against unexpectedly high losses to the plan. See Cantor,
supra note 154, at 195. There is some debate as to whether employers should be entitled
to the advantages of self-insurance when stop-loss insurance attaches at a low dollar
amount. See Dennis K. Schaeffner, Comment, Insuring the Protection of ERISA Plan
Participants, 47 BUFF. L. REV. 1085 (1999) (discussing cases addressing the effect of
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Coverage decisions in ERISA plans are within the purview of the plan
administrator.15 7 In insured ERISA plans, the risk-bearing entity with whom the
employer contracts generally also contracts to assume some administrative
duties, such as record keeping and notification, eligibility determinations, and
review of claims for benefits. Employers who self-insure typically delegate
many administrative functions relating to the management and operation of the
plan to third-party administrators ("TPAs"), including duties relating to claims
determinations. TPAs are often insurance companies or other managed care
organizations that administer, for the self-insured employer, plans virtually
identical to their plans offered to employers who sponsor insured plans-the
only real difference being that the self-insured employer retains the risk of
coverage. Thus, in the health benefit context, for both insured and self-insured
plans, the employer generally contracts with a distinct entity that administers
claims for benefits-the TPA or the risk-bearing entity that underwrites insured
plans. 158
The procedures for claims administration may take a multitude of forms.
Nonetheless, the procedures for claiming benefits in most plans are but
variations of a standard model.'59 The initial coverage decision is made by a
claims manager (often a nurse) who is an employee of the administrator. Denials
generally must be referred for special consideration to a physician or other
appropriate health professional, also employed by the administrator."6 In one
variation on this model, as in the Corcoran case, some administrators may
contract with a distinct UR entity that makes the coverage determination and
sometimes handles appeals. Thus, the typical claims process for claims in
ERISA plans involves only employees or agents of the TPA or the risk-bearing
157. ERISA plans generally involve four parties: "(1) the employer, who makes
the contributions to the plan; (2) the plan administrator, who administers the plan; (3) the
trustee, who invests the plan's funds; and (4) the employee/beneficiary, who receives the
benefits." George Lee Flint, Jr., ERISA: The Arbitrary and Capricious Rule Under
Siege, 39 CATH. U. L. REV. 133, 137 (1989). The plan administrator is the key party in
health coverage plans. The role of plan administrator can be performed by different
persons or entities: the employer, a management employee (or a committee of
management employees), a service provider, such as an insurance company operating
under an administrative contract with the plan, or a committee of equal numbers of
representatives from management and from the rank and file employees. Id. at 137-38.
158. Indeed, TPAs are often insurance companies that have contracted solely to
perform administrative functions.
159. See, e.g., Crocco v. Xerox Corp., 956 F. Supp. 129 (D. Conn. 1997), aff'd in
part, rev'd in part, 137 F.3d 105 (2d Cir. 1998).
160. Indeed, some states are beginning to require that medical necessity
determinations made by HMOs or other managed care plans be performed only by
physicians licenced to practice medicine within the state. See Medical Necessity
Decisions Must Be Made By Licensed Physician, Attorney General Says, HEALTH L. REP.
(BNA), June 3, 1999, at 903.
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entity with whom the employer has contracted, or a distinct entity contracted to
provide UR services.
Upon a denial of coverage, the plan participant or beneficiary has several
options. One option is to initiate an internal appeal.' Alternatively, if the plan
beneficiary believes the denial resulted from a negligent medical determination,
a state tort suit would be an option-if the suit is not preempted by ERISA. The
proper defendant in such a suit would be the TPA or the managed care entity
with whom the plan sponsor contracted to perform UR services. Thus, any tort
duty to use care arising as a result of a claim challenging a negligent medical
decision would fall directly on those entities conducting UR-and not on
employers or ERISA plans. 62 The only effect on the employer or plan sponsor
would be costs passed through to ERISA plans in the form of higher premiums
or higher administrative costs. The Supreme Court in Travelers held that this
type of indirect economic effect is generally insufficient to trigger preemption.
Further, any difference in state tort law that might emerge would have only
a minimal effect on benefit structure or plan administration and thus would not
hinder interstate ERISA plans. First, any difference in the substantive tort law
would be minimal. The tort duty likely to be imposed would require utilization
reviewers to use reasonable care in making determinations of medical necessity.
What evolves as being "unreasonable" may differ slightly from jurisdiction to
jurisdiction depending on the standard of care applied and any resulting jury
verdicts. But, as in the case of malpractice suits against physicians, although
161. The internal appeal may be to a medical director employed by the
administrator or an "appeals committee" comprised of persons with some medical
expertise and selected by (and often compensated by) the administrator.
162. Notably, the federal district court in Corporate Health Ins. Inc. v. Texas Dep 't
ofIns., 12 F. Supp. 2d 597 (S.D. Tex. 1998), held that managed care plans are not ERISA
plans. In Corporate Health, managed care entities affected by the Texas liability
provision brought suit challenging the law as being preempted by ERISA. See supra
note 101; infra note 200 (describing the Texas liability provision). The State of Texas
argued that the plaintiffs:
[B]lurr[ed] the distinction between an ERISA plan (established by an
employer to provide benefits to an employee) and a health plan (established
by health insurance entities as a vehicle for bearing the risks of health
insurance and providing coverage to an ERISA plan for those employees).
Aetna admits plaintiffs 'offer products in the form of managed health care
coverage to employees who are enrolled in ERISA ... plans in Texas.' Aetna
may operate as a 'health plan," but Aetna is not an ERISA plan established
by an employer.
Id. at 609. The court agreed, stating that the plaintiffs are "medical service providers to
ERISA plans and their members. Plaintiffs operate health plans rather than ERISA
employee benefit plans." Id.
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such differences may affect litigation,' 63 they likely would have only a negligible
effect on conduct.'"
Second, it is implausible that any differences that might emerge would
cause any significant changes in plan administration or benefit structure.
Employers or plan sponsors could, and would, continue to contract for plans
using UR and other managed care practices. 6s Similarly, even if there would be
a minimal effect on what medical services would be covered by the ERISA
benefit plan, the Court in Travelers made clear that preemption is not warranted
when a state law results in some increased costs being passed through to the
employer, causing the employer to reduce coverage. Thus, allowing suits arising
from allegedly negligent medical decisions to proceed would only indirectly and
insubstantially affect employers or ERISA plans.
b. A Corcoran-Type Claim Promotes Employee Interests
At the same time, allowing suits against managed care plans for negligent
medical decision making is consistent with the congressional interest in
protecting employees' interests. In enacting ERISA, Congress sought to protect
163. Cf Jacobson & Pomfret, supra note 58, at 1066 (noting that differences in tort
law may lead to procedural differences and differences in methods of proof, such as the
standard for expert witnesses).
164. Cf Jacobson & Pormfret, supra note 58, at 1066-67 (noting (1) that although
the standard by which the medical decision will be judged may differ slightly across state
lines, the burden imposed on utilization reviewers would not interfere with uniform
policies, and (2) that many commentators have pointed to the growing trend toward a
national standard of care). Injustifying the trend toward a national standard of care for
judging the exercise of medical decision making, one court aptly explained:
Medical school admission standards are similar across the country.
Curricula are substantially the same. Internship and residency programs for
those entering medical specialties have substantially common components.
Nationally uniform standards are enforced in the case of certification of
specialists. Differences and changes in these areas occur temporally, not
geographically.
Physicians are far more mobile than they once were. They frequently
attend medical school in one state, do a residency in another, establish a
practice in a third and after a period of time relocate to a fourth. All the while
they have ready access to professional and scientific journals and seminars for
continuing medical education from across the country. Common sense and
experience inform us that the laws of medicine do not vary from state to state
in anything like the manner our public law does.
Hall v. Hilbum, 466 So. 2d 856, 870 (Miss. 1985), quoted in Jacobson & Pomfret, supra
note 58, at 1066 n.511.
165. Cf. Jacobson & Pomfret, supra note 58, at 1066 (noting that, even if there is
some difference in state tort law, the differences do not suggest that the coverage policy
for which an employer or ERISA plan sponsor contracts in order to provide health
benefits must be different).
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employees in several ways." The preemption provision itself was intended to
protect employees as much as employers. By preempting state laws that
impermissibly effect ERISA plans, the provision encouraged employers to create
or maintain benefit plans by permitting multistate employers to offer a single
plan to all employees without the cost and inconvenience of complying with
contradictory state regulations. Other provisions allow plan participants and
beneficiaries to bring a federal civil action to recover benefits due and to enforce
terms of the plan; and they require plan fiduciaries, in carrying out their
functions, to act solely in the interests of plan participants and beneficiaries.167
Thus, Congress intended to do more than simply create a bare right to benefits;
Congress also tried to ensure that benefits would be provided in a reasonable
manner.1
68
Allowing tort suits challenging negligent medical decisions is consistent
with the protection Congress sought to ensure for employees. Tort suits would
protect employees' legitimate expectations that managed care plans will use
reasonable care in exercising medical judgment and that plans can be held
accountable for deviations that cause injury. At the same time, the resulting
costs to managed care plans, which are passed on to employers, are not likely to
166. See Dahlia Schwartz, Note, Breathing Lessons for the ERISA Vacuum:
TowardA Reconciliation ofERISA 's Competing Objectives in the Health Benefits Arena,
79 B.U. L. REv. 631, 635-36 (1999). Schwartz explains: -
Congress enacted ERISA in response to three related problems that attained
national prominence in the early 1970s. First, in the absence of
comprehensive national or state regulation, many employers underfunded
employee pension plans.... Second, pension plan administrators, although
obligated to act as fiduciaries of the trusts they administered, faced few and
inadequate remedial consequences for breaches of their fiduciary duty....
Third, corporations engaged in interstate commerce faced complex and
myriad state regulations designed to address the previous two concerns.
Id. at 636.
167. For ERISA's civil enforcement provisions, see § 502(a) of ERISA, codified
at 29 U.S.C. § 1132 (1994). Some have noted that protecting employees' interests in
their benefits was the primary purpose underlying the ERISA provisions that apply to
health plans. See Jacobson & Pomfret, supra note 58, at 999-1001.
168. Congress explicitly noted that its policy objectives in enacting ERISA
included the protection of:
[T]he interests of participants in employee benefit plans and their
beneficiaries, by requiring the disclosure and reporting to participants and
beneficiaries of financial and other information with respect thereto, by
establishing standards of conduct, responsibility, and obligation for
fiduciaries of employee benefit plans, and by providing for appropriate
remedies, sanctions, and ready access to the Federal courts.
29 U.S.C. § 1001(b) (1994).
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dissuade a significant number of employers from offering plans or to cause
employers to discontinue plans. 16
9
In sum, an implied preemption analysis suggests that Corcoran-type
claims--claims against managed care plans for negligent medical decision
making-should not be preempted. Congressional purposes would not be
frustrated, and the balance established by Congress would be maintained.7' The
modifications to the preemption analysis established by the trilogy of Supreme
Court cases have therefore greatly undermined the reasoning of the Corcoran
decision.
3. Why Have Lower Courts Continued to Follow Corcoran?
As noted, most lower courts have continued to follow Corcoran despite the
Supreme Court trilogy. A distinct issue, then, is why: Why have lower courts
steadfastly clung to the reasoning in Corcoran if the trilogy suggests that
Corcoran was wrongly decided? The answer to this question is, of course,
multifaceted. But two reasons seem most likely. In part, the reluctance to
deviate from Corcoran may stem from the fact that the state laws involved in the
Supreme Court trilogy were riot state common law actions, but instead were
provisions enacted by state legislatures. Thus, lower courts may believe that the
Supreme Court holdings do not directly govern the issue of preemption of state
common law actions, and that common law actions must continue to be
governed by Pilot Life and Corcoran.'
However, nothing in the Supreme Court cases suggests that the modified
preemption analysis applies only to state legislative provisions. Rather, the
trilogy broadly governs an analysis of preemption under § 514(a) of ERISA.
Under § 514(a), state laws are preempted if there is a sufficient "connection with
or reference to" ERISA plans. The trilogy, as discussed in this Article,
169. In 1998, the General Accounting Office ("GAO") criticized widely quoted
estimates, used by health insurance and business groups, that suggested that 400,000
individuals would lose health coverage for every one percent increase in premium costs.
See Insurance Regulation: GAO Criticizes Lewin Group's Prediction on Coverage Loss
Due to Premium Hikes, HEALTH CARE DAILY REP. (BNA), Aug. 6, 1998, at d9, available
in WL 8/6/1998 HCD d9. The GAO was hesitant to produce its own estimates, noting
the many unknown factors that could affect the estimates. Id.
170. But see Huss v. Green Spring Health Servs., Inc., 18 F. Supp. 2d 400 (D. Del.
1998) (concluding, with little discussion, that preemption of a state tort claim, "although
regrettable, necessarily furthers" the congressional goal of uniformity and minimization
of administrative and financial burdens on ERISA plans).
171. Cf Benoit v. Grainger, Inc., No. Civ.A. 98-1315, 1998 WL 749444, at *3
(E.D. La. Oct. 21, 1998) (noting that the facts in the Supreme Court's Dillingham
decision were not sufficiently analogous to the case at hand to warrant disregarding
Corcoran, and stating that "nothing in Dillingham... directly or indirectly suggests that
Corcoran is no longer good law").
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established a different focus for resolving the issue of whether a state law is
preempted due to a "connection with" ERISA plans. 72 And the Court in
Travelers expressly included in this category of laws that may be preempted,
state common law actions that the Court had found to be preempted.'73 Thus, it
is reasonable to conclude that the modified preemption analysis applies to state
common law actions as well as to state legislative provisions.
A second reason for the reluctance to deviate from Corcoran may stem
from the fact that lower courts are unsure how to distinguish Pilot Life, which
purportedly dictated the holding in Corcoran174 In Travelers, the Court
purportedly did not overrule any of its prior preemption decisions, and lower
courts may feel constrained by the prior Supreme Court holding. However, a
tort suit arising from an allegedly negligent medical decision can be
distinguished from the claims involved in Pilot Life. In Pilot Life, Dedeaux's
claims for tortious breach of contract, breach of fiduciary duties, and fraud arose
from the fact that Pilot Life granted, terminated, reinstated, and terminated again
Dedeaux's claim for disability benefits.' 75 Dedeaux's claims were characterized
as arising from "improper processing of his claims for benefits."' 7 6
Unfortunately, the facts in the case are sparse, and it is unclear why Dedeaux's
172. However, the Dillingham decision also addressed preemption due to a
"reference to" ERISA plans. See California Div. of Labor Standards Enforcement v.
Dillingham Constr. Inc., 519 U.S. 316,324-25 (1997).
173. Specifically, the Court in Travelers cited to Ingersoll-Rand Co. v. McClendon,
498 U.S. 133 (1990). In Ingersoll-Rand, the Court held that ERISA preempted a
common law cause of action recognized by the Texas Supreme Court that permitted
plaintiffs to recover in a wrongful discharge action if the plaintiff could show that the
principal reason for the termination was the employer's desire to avoid contributing to
or paying benefits under the employee's pension fund. According to the Court, the state
cause of action was preempted because it directly conflicted with § 510 of ERISA, which
protects employees from termination motivated by an employer's desire to prevent a
pension from vesting. Id. at 143-44. Thus, the Texas cause of action represented an
"alternate enforcement mechanism" to ERISA § 510. A secondary reason for preemption
also existed: the cause of action was premised on the existence of an ERISA plan (i.e.,
an ERISA plan was critical to the law's operation), and thus the law impermissibly
"referenced" ERISA plans.
174. Cf Parrino v. FHIP, Inc., 146 F.3d 699, 705 n.3 (9th Cir. 1998) (noting that
the Supreme Court has not overturned it prior substantive holdings and finding the state
claims at issue preempted because the claims were based "upon alleged improper
handling of this claim for treatment"); Turner v. Fallon Community Health Plan, Inc.,
127 F.3d 196, 199 & n.1 (1st Cir. 1997) (citing Pilot Life Ins. Co. v. Dedeaux, 481 U.S.
41, 52-57 (1987) and noting that "[h]owever [the] general language [of § 514(a)] might
otherwise have been read, the Supreme Court has construed it to preclude state claims to
enforce rights under an ERISA plan or to obtain damages for the wrongful withholding
of those rights... and this construction has been repeatedly followed").
175. See Pilot Life, 481 U.S. at 43-44.
176. Id. at 48, 57.
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disability benefits were provided in an "on-again, off-again" manner. However,
there are two likely possibilities. First, Pilot Life may have had in place a faulty
process for administering disability benefits, e.g., perhaps claims for benefits
were neglected, or perhaps authorized benefits automatically expired after a
certain period of time. Second, because disability benefits were at issue, the
termination and reinstatement likely stemmed from findings regarding whether
Dedeaux was in fact "disabled." Whether an individual is "disabled" and thus
qualifies for disability benefits hinges on the individual's ability to work.
177
Regardless of which reason formed the basis of the denial in Pilot Life, it is clear
that Dedeaux was not challenging a decision about what medical care or
treatment was necessary or reasonable. The claim at issue in Pilot Life is
therefore distinguishable from the type of claim at issue in Corcoran.
Accordingly, because the recent trilogy of Supreme Court cases
substantially undermines the reasoning underlying the Corcoran decision rather
than steadfastly following Corcoran, lower courts should conduct a careful
reevaluation of whether Congress intended ERISA to preempt tort actions arising
from coverage denials in which the conduct being challenged involved an
exercise of medical judgment.
4. The Demise of Corcoran Does Not Completely Resolve
the Preemption Problem
This Article explained the scope of the preemption problem for ERISA plan
participants and beneficiaries as being largely shaped by Corcoran. Thus, it
might seem logical to assume that, if recent Supreme Court precedent has
undermined the reasoning underlying Corcoran, the preemption problem has
been completely eviscerated and a federal amendment to ERISA is unnecessary.
But that conclusion does not automatically follow. Although it is accurate to
describe Corcoran as establishing that ERISA preempts all state and contract
claims arising in any way from a health-benefit determination, Corcoran itself
involved only a wrongful death action based on an allegedly negligent
determination that hospitalization was not medically necessary. Thus, the
177. A disability benefit plan provides income-replacement benefits to employees
who are unable to work because of illness or accident. Because the benefit is "income"
and not reimbursement for medical services, the amount of disability income an
employee collects depends on his or her pre-disability income level and not on the type
or severity of the disability suffered. The type or severity of a disability is relevant to
whether benefits are due because disability plans typically provide benefits only for
individuals who become totally disabled and unable to work. See Stephen F. Befort,
Mental illness and Long-Term Disability Plans Under the Americans With Disabilities
Act, 2 U. PA. J. LAB. & EMP. L. 287 (1999). The focus of the inquiry in determining
benefits, then, is whether the plan participant or beneficiary is able to work. See, e.g.,
Garner v. Heckler, 745 F.2d 383 (6th Cir. 1984); Giampa v. Trustmark Ins. Co., 73 F.
Supp. 2d 22 (D. Mass 1999).
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demise of Corcoran actually eviscerates the preemption problem only as to
coverage denials involving an exercise of medical judgment, and it may have
little bearing on the preemption of actions based on the other type of coverage
denial, i.e., denials arising from conduct that involves contractual interpretation
or application, but not from an exercise of medical judgment.
As this Article explained in Part II, a denial arising from conduct that
involves contractual interpretation or application, but not an exercise of medical
judgment, is more akin to the traditional process of determining insurance claims
and coverage. The basis for a denial would include reasons such as (1) the
service did not fall within a category of services covered by the policy, (2) the
service fell within the scope a specific exclusion in the policy, (3) the service
exceeded the quantity allowed under the policy, or (4) the service was
improperly accessed. Thus, a state common law action seeking damages arising
from a more traditional coverage denial is predominately contractual in nature
and less like a negligence-based, Corcoran-type claim. A distinct issue,
therefore, is whether, under a narrower view of preemption, it continues to be
appropriate to construe ERISA as preempting claims arising from coverage
denials based on conduct involving contractual interpretation or application, but
not exercises of medical judgment.
A more contractually based cause of action would similarly benefit from the
presumption against preemption. However, a contract-based cause of action is
not readily characterized as a regulation of the "quality" of health care; even if
the claim asserted is "tortious" breach of contract, the tort aspect of the claim is
premised on the plan's violation of the contractual duty of good faith and fair
dealing. 7s Thus, Travelers cannot as readily be construed as bearing on the
question of preemption of a more contractually based claim. A contract-based
claim also is less easily distinguished from the type of claim at issue in Pilot Life.
Indeed, the plaintiff in Pilot Life asserted a tortious breach of contract claim, and
the Supreme Court found that the claim was preempted.
Significantly, however, the Court's analysis in Pilot Life focused largely on
the fact that Dedeaux's claim was inconsistent with § 502(a)(1)(B) of ERISA,
a subsection of ERISA's civil enforcement provision. Thus, actions arising from
a denial of coverage based on conduct that does not involve an exercise of
medical judgment may have more than mere economic effects on ERISA plans.
These actions may be inconsistent with § 502(a)(1)(B) and, if so, they would be
preempted for that reason. Accordingly, in assessing the need for a federal
legislative solution to the preemption problem, it is necessary to also consider the
recent case law developments relating to § 502(a) of ERISA. The following
178. Most states have recognized that insurers are subject to a duty to act in good
faith and to deal fairly with their insureds. An insurer's breach gives rise to a cause of
action for tortious breach of contract. The cause of action is intended to compensate the
insured for injury caused by the insurer's wrongful conduct, not for benefits covered by
the policy. See infra notes 224-29 and accompanying text (discussing preemption of a
claim for tortious breach of contract).
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section of this Article explains the interaction between § 502(a)(1)(B) of ERISA
and § 514(a) of ERISA and analyzes the extent to which the emerging
§ 502(a)(1)(B) case law has eviscerated the preemption problem for ERISA plan
participants and beneficiaries in cases involving coverage denials.
B. Courts of Appeals Decisions Narrowing the Scope of
§ 502 (a) (1) (B)
While ERISA § 514(a) contains Congress's express statement regarding
preemption, § 502(a) of ERISA also plays a significant role in determining the
scope of ERISA preemption. The Court noted in Travelers that some state laws
it had previously found to be preempted because of their "connection with"
ERISA plans were state laws that constituted "alternative enforcement
mechanisms."' 79 Thus, a state law may be preempted under § 514(a) because the
law is inconsistent with § 502(a).180 Because of this relationship between
§ 514(a) and § 502(a), a distinct issue is whether that type of action could be
preempted due to a conflict with § 502(a)(1)(B) of ERISA even though the
foregoing section of this Article concluded that tort actions challenging an
allegedly negligent medical decision should not be found preempted under the
more pragmatic approach to § 514(a) preemption. This section analyzes the
question of preemption due to a conflict with § 502(a)(1)(B) as to both types of
coverage denials.
As noted, the plaintiff in Pilot Life asserted claims for tortious breach of
contract, breach of fiduciary duties, and fraud. The Court in Pilot Life supported
its holding that Dedeaux's state law claims were preempted because they
"related to" ERISA plans by noting that allowing a state action based on the
"improper processing of his claims for benefits" would be inconsistent with
§ 502(a)(1)(B). More specifically, the Court in Pilot Life explained that
Congress intended § 502(a)(1)(B) to be the exclusive vehicle for actions by
ERISA plan participants and beneficiaries asserting improper processing of a
claim for benefits. 8 ' One way of assessing whether a claim is preempted due to
179. New York State Conference of Blue Cross & Blue Shield Plans v. Travelers
Ins. Co., 514 U.S. 645, 658 (1995). The Court was referring to cases in which state
common law actions had been found preempted because the actions were inconsistent
with suits authorized by § 502(a). Id. (citing Ingersoll-Rand Co. v. McClenden, 498 U.S.
133 (1990)).180. Section 502(a), ERISA's civil enforcement provision, is so central to ERISA
preemption analysis that some scholars and courts distinguish between § 514(a)
preemption and § 502(a) preemption. See, e.g., ROSENBLATT ET AL., supra note 17, at
65, 71, 187 (distinguishing between preemption under § 514(a) and preemption due to
a conflict with § 502(a)).
181. See Pilot Life Ins. Co. v. Dedeaux, 481 U.S. 41, 52 (1987). Further, the Court
stressed that courts should not find, in claims brought under § 502(a), any implied right
to remedies; rather, according to the Court, § 502(a):
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the scope of § 502(a)(1)(B), then, would be to focus on the phrase "improper
processing of a claim for benefits." This language is sufficiently open-ended that
it could be construed as encompassing any action arising from any aspect of a
benefit determination-and thus as requiring preemption of actions arising from
both categories of coverage denials. Indeed, the Corcoran court viewed the
phrase in that way.
Yet, as this Article has pointed out, a tort suit arising from a negligent
medical determination is readily distinguishable from the type of claims involved
in Pilot Life. Thus, although a tort suit challenging a negligent medical
determination arises from one distinct aspect of the benefit determination
process, such a claim should not necessarily be characterized as falling within
the scope of the phrase "improper processing of a claim for benefits" as that
phrase was used in Pilot Life. Accordingly, if the phrase "improper processing
of a claim for benefits" is not sufficiently refined to identify the claims that
should be preempted, then the phrase is not the appropriate focus for the
preemption analysis. Rather, the focus of the preemption analysis should simply
be whether a claim is inconsistent with the language of § 502(a)(1)(B).
Section 502(a)(1)(B) of ERISA authorizes suits "to recover benefits due...
under the terms of [the] plan, [and] to enforce... rights under the terms of the
plan .... 82 Because the Supreme Court has never clarified when a state
common law suit constitutes an action within the scope of § 502(a)(1)(B), it
becomes appropriate to look to recent circuit courts of appeals decisions that
have narrowed the scope of state common law claims that fall within
§ 502(a)(1)(B), namely, Dukes v. US. Healthcare, Inc." and Rice v. Panchal."
Although the claims in these cases did not involve allegedly negligent coverage
determinations, the decisions are instructive. 8 ' The analysis in each was limited
[R]epresents a careful balancing of the need for prompt and fair claims
settlement procedures against the public interest in encouraging the formation
of employee benefit plans. The policy choices reflected in the inclusion of
certain remedies and the exclusion of others under the federal scheme would
be completely undermined if ERISA plan participants and beneficiaries were
free to obtain remedies under state law that Congress rejected in ERISA.
Id. at 42.
182. See 29 U.S.C. § 1132(a) (1994). Section 502(a)(1)(B) also authorizes an
action "to clarify ... rights to future benefits under the terms of the plan." This part of
the provision, however, is unlikely to be triggered by a state tort suit.
183. 57 F.3d 350 (3d Cir.), cert. denied, 516 U.S. 1009 (1995).
184. 65 F.3d 637 (7th Cir. 1995).
185. In Dukes, the plaintiffs alleged that their HMOs were vicariously liable for the
negligence of participating providers and directly liable for negligent selection, retention,
and oversight of the HMOs' participating providers. In Rice, the plaintiff alleged only
a vicarious liability claim against the insurer that administered the plaintiffs managed
care plan for injuries sustained in the course of medical treatment.
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* to the question of whether the common law claims at issue were preempted by
virtue of § 502(a)(1)(B)' 86
The court in Dukes focused on whether the alleged vicarious liability and
direct negligence claims could constitute suits "to recover benefits due." In
contrast, the court in Rice analyzed whether a vicarious liability claim could
constitute a suit "to enforce rights under the terms of the plan." The following
subsections explain the approaches used by these courts in determining whether
state common law actions fall within the scope of § 502(a)(1)(B) and consider
their impact on claims rising from denials based on an exercise of medical
judgment as well as on claims based on denials not involving an exercise of
medical judgment.
1. Suits to Recover Benefits Due Under the Terms of the Plan
a. The Dukes Analysis: A Quantity-Quality Test
At issue in Dukes were two types of claims against HMOs: a vicarious
liability claim arising from the negligent provision of medical care by providers
within the HMO network, and a direct negligence claim challenging the selection
186. In both cases, the plaintiffs originally had filed common law tort claims in
state court. The defendants raised the issue of ERISA preemption and then removed the
actions from state court to federal court. Removal to federal court is authorized if, on the
face of the complaint, it appears that the plaintiff could have filed the action in federal
court. See 28 U.S.C. § 1441 (1994); Louisville & Nashville KR. v. Mottley, 211 U.S.
149, 153-54 (1908) (establishing the parameters of the well pleaded complaint rule). The
issue in both cases therefore was whether the actions were properly removed by virtue
of the doctrine of complete preemption. Both courts explained that actions alleging state
law tort claims are not automatically removable to federal court when a defendant raises
the defense of ERISA preemption. Rather, under the doctrine of complete preemption,
the actions would be removable only if the plaintiffs' claims could be recharacterized as
federal claims; namely, claims within the scope of § 502(a). See Rice, 65 F.3d at 640.
The Supreme Court recognized the doctrine of complete preemption in ERISA cases in
Metropolitan Life Ins. Co. v. Taylor, 481 U.S. 58 (1987).
Thus, rather than questioning the "effect" on ERISA plans, the courts addressed
only whether the state tort claims were within the scope of § 502(a)(1)(B). Notably, a
state law claim that is not within the scope of § 502(a) of ERISA may nonetheless be
preempted because of its effect on an ERISA plan. In such a case, the generally
recognized practice is to remand the action to state court for determination of the
question of ERISA preemption on a basis other than § 502(a). The decisions in Rice and
Dukes should go a long way toward clarifying the distinction between preemption and
the doctrine of complete preemption and whether an action involving a state tort claim
against a managed care plan is removable. However, they have also highlighted the
inefficiencies associated with removal since the ERISA preemption analysis becomes
split between federal and state courts. See generally Karen A. Jordan, The Complete
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and retention of providers in the HMO network. The issue was whether these
claims could constitute suits "to recover benefits due." A threshold issue in
resolving whether a state common law claim may be characterized as a suit to
"recover benefits due" is what constitutes "benefits" under the plan. The court
in Dukes assumed, without deciding, that medical care is a benefit for purposes
of a § 502(a)(1)(B) analysis when the health benefits are provided through an
IMO.18 7 In reaching its decision that the claims did not constitute a suit to
recover benefits due, the court in Dukes created a test seemingly based on
whether the suit challenges the "quality" or "quantity" of benefits provided
under the ERISA plan.
The court's conclusion that the claims did not constitute a suit to recover
benefits due hinged on the fact that the claimants in the case were not alleging
that the HIMOs had withheld some "quantum" of medical care due. The court
held that a suit "to recover benefits due.., is concerned exclusively with
whether or not the benefits due under the plan [medical care] were actually
provided."' 88 As noted, the claims at issue were a vicarious liability claim
arising from negligent provisions of medical care by providers within the HMO
network and a direct negligence claim challenging the selection and retention of
providers in the HMO network. As to both claims, the court found that the
plaintiffs were challenging the low "quality" of the medical care and treatment
they received rather than the "quantity" of care received.'89 The court in Dukes
thus held that a suit against a managed care plan is not a suit to "recover benefits
due" when the claim stems from medical care received, and the plaintiff is
challenging either the quality of the medical care itself or certain conduct by the
managed care plan that directly affects the quality of medical care provided
under the plan. 9
In addition to creating a "quantity-quality" test, the court in Dukes
suggested that the quantity prong of the test could trump the quality prong. This
aspect of the Dukes decision is derived from the court's attempt to distinguish
Corcoran. The court explained that the direct negligence claim involved in
Corcoran challenged only the managed care function of UR whereas the claims
in Dukes challenged only the function of "arranging" medical care for plan
187. Dukes, 57 F.3d at 356.
188. Id. at 357. In Rice, the plaintiff similarly alleged a vicarious liability claim
based on negligent treatment received. The court merely made a conclusory statement
that the plaintiff had not alleged that he did not receive the benefits (payments) due under
the plan, and thus the claim was not "to recover benefits." Rice, 65 F.3d at 642.
189. Dukes, 57 F.3d at 356-57.
190. However, the court in Dukes noted that an exception might exist. For
example, if the quality of the medical care rendered is so low that the treatment does not
qualify as health care at all, then the distinction between the "quantity" of benefits due
and the "quality" of benefits becomes a distinction without a difference. Dukes v. U.S.
Healthcare, Inc., 57 F.3d 350, 358 (3d Cir.), cert. denied, 516 U.S. 1009 (1995). In such
a case, a suit challenging the quality of care could be characterized as a suit for benefits.
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beneficiaries, by selecting and supervising the physicians who comprised the
HIIMO's network. According to the court, that distinction was crucial because
"only in a utilization-review role is an entity in a position to deny benefits due
under an ERISA welfare plan.. 19' Like other courts striving to remain consistent
with Corcoran, the Dukes court also suggested that characterizing challenged
conduct as medical decision making is not determinative. Thus, Dukes can be
construed (and some courts have construed it) as implying that an action
challenging conduct involving an exercise of medical judgment (e.g., arranging
for care) still might be preempted if it also involves a challenge to conduct
involving a denial of care.9 Thus viewed, the quantity prong of the test seems
to be determinative. In other words, a challenge to the quality of benefits due
(e.g., medical care) is nonetheless preempted if the action arises from a coverage
denial.
b. The Impact on the Reasoning Underlying Corcoran
At first blush, it may appear that the Dukes decision does little to undermine
the reasoning underlying Corcoran if the test is a "quality-quantity" test with the
quantity prong being determinative. This is because the claim in Corcoran could
be described as a claim challenging the "quantity" of benefits since the claim
arose from United's denial of coverage for hospital benefits. Indeed, as noted,
the court in Dukes explicitly attempted to harmonize its decision with the
Corcoran opinion. However, it is important to emphasize that the holding in
Dukes was that certain state law claims were not inconsistent with
§ 502(a)(1)(B). Further, because the claims at issue in Dukes did not arise from
a coverage denial, the issue before the court did not require the court to consider
or evaluate the correctness of Corcoran. Like other courts, the court in Dukes
simply supported its decision by pointing out that it was not inconsistent with
Corcoran.
Understanding that the aspect of Dukes which suggested that the quantity
prong of the test would trump the quality prong was dicta is important. Because
it was dicta, the essence of the Dukes decision is that state law actions
challenging the quality of benefits due under the plan (e.g., medical care) are not
inconsistent with § 502(a)(1)(B), and whether the fact that the action also arises
from a benefit denial (the "quantity" prong of the test) should trump the quality
prong is a distinct issue. If not, rather than a "quantity-quality" test, the test
191. Id. at 360-61.
192. See, e.g., Delucia v. St. Luke's Hosp., No. Civ.A. 98-6446, 1999 WL 387211,
at *3 (E.D. Penn. May 25, 1999). Notably, although the court in Dukes suggested that
the "UR" function and the "arranging for care" function were distinct, it may be more
accurate to describe the UR function as a subset of the overarching function of arranging
for care. Thus, rather than thinking that some HMOs perform one function and other
HMOs perform the other, it is better to perceive all HMOs as arranging for care for their
enrollees, but that some also perform the function of UR.
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should simply be whether a state common law action constitutes a challenge to
the quality of benefits.
The following subsections explain why a "quality" standard is more
justifiable for preemption purposes than a "quantity-quality" distinction, identify
emerging case law supporting use of a simple quality test, and apply a "quality"
standard to a state actions challenging coverage denials. The analysis shows that
actions arising from coverage denials involving an exercise of medical judgment
are not inconsistent with § 502(a)(1)(B), but that actions arising from coverage
denials that do not involve an exercise of medical judgment may be inconsistent
with § 502(a)(1)(B).
(i) A Simple Quality Test Is More Justifiable
In light of recent Supreme Court precedent, it is unwarranted to allow the
"quantity" prong of the Dukes test to trump the fact that a state common law
claim is challenging the quality of medical decision making. Rather, the fact that
a state claim challenges conduct involving medical decision making should
trump the fact that the suit may also involve a benefit denial.' This conclusion
flows from the relationship between § 514(a) and § 502(a) of ERISA.
As explained, because of the relationship between § 514(a) and § 502(a),
a state law may be preempted under § 514(a) because the law is inconsistent with
§ 502(a).' 93 Understood this way, preemption due to a conflict with § 502(a) is
but a subset of the preemption set forth in § 514(a). This is consistent with the
view that § 514(a) reflects Congress's expression of the outer bounds of
preemption by ERISA. But if these premises are correct, preemption due to a
conflict with § 502(a) cannot logically reach state laws that the Supreme Court
has suggested are not preempted under § 514(a). In Travelers, the Supreme
Court explained that Congress did not intend § 514(a) of ERISA to preempt state
laws regulating the quality of health care. If § 514(a) should not be construed
as preempting state laws regulating the quality of health care, then it is also
logical to conclude that § 502(a)(1)(B) should not be construed as preempting
state laws regulating the quality of health care.
The essence of medical decision making occurring in the context of UR is
fundamentally no different than medical decision making by a managed care
enrollee's treating physician.194  Both represent clinical decisions, i.e.,
individualized application of medical knowledge and judgment to clinical
symptoms in order to determine whether a particular medical treatment or
service is medically necessary.'95 Permitting a state tort action challenging
medical decision making thus represents regulation of the quality of health care
delivery, and this seems especially evident when the medical decision is made
193. See supra notes 179-80 and accompanying text.
194. See supra notes 32-38 and accompanying text.
195. Cf Jacobson & Pomfret, supra note 58, at 1064-65.
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in the context of UR, where resource considerations are admittedly more
influential.'96 Thus, when a tort suit is seeking to challenge conduct involving
medical decision making, the fact that the suit may also arise from facts which
may be characterized as a denial of benefits should not suffice to cause
preemption. Accordingly, the better approach is to focus on the essence of the
Dukes decision-that a state common law cause of action regulating the quality
of medical decision making is not inconsistent with § 502(a)(1)(B) and should
not be preempted.
The justification for making the quantity prong determinative flows from
concerns about permitting a plaintiff to recover damages for personal harm
caused by a coverage denial. The Supreme Court has held that a § 502(a)(1)(B)
suit to "recover benefits due" authorizes ERISA plan participants and
beneficiaries to recover just that-benefits-but no extracontractual damages. 197
For example, Florence Corcoran was denied coverage for hospitalization. Under
§ 502(a)(1)(B), the only remedy she could seek would have been coverage for
hospitalization, which she of course no longer needed. Further, the Court has
similarly held that other § 502(a) actions do not authorize recovery of monetary
damages to individuals.'98 Lower courts have used these Supreme Court
holdings to justify the view that any state law cause of action that allows
claimants to recover "damages" for harm caused by a coverage denial is
inconsistent with § 502(a)(1)(B) and thus preempted. 199 But an inconsistency
exists only if it is true that Congress intended to preempt all state common law
actions arising from a coverage denial-including actions that represent a state
law regulation of the quality of medical decision making.
Thus, courts have been approaching the issue backwards. That is, courts
have allowed their view that Congress intended § 502(a) to provide the exclusive
remedies for ERISA plan participants and beneficiaries to effect the scope of
§ 514(a) preemption. But, § 514(a) is Congress's expression of the outer bounds
of preemption. The scope of § 514(a) preemption should therefore impact the
courts' view of what actions should be found inconsistent with § 502(a)(1)(B),
rather than the other way around. And given Travelers's clarification of the
scope of the laws Congress intended to preempt, actions arising from coverage
denials involving medical decision making should not be found preempted.
196. Resource considerations enter into the clinical decision in both situations, but
especially when the clinical decision is being made in the context of UR for a managed
care health plan.
197. See, e.g., Massachusetts Mutual Life Ins. Co. v. Russell, 473 U.S. 134, 148
(1985).
198. See, e.g., Varity Corp. v. Howe, 516 U.S. 489, 512-13 (1996); Mertens v.
Hewitt Assocs., 508 U.S. 248, 260 (1993).
199. See, e.g., Hull v. Fallon, 188 F.3d 939 (8th Cir. 1999), cert. denied, 120 S. Ct.
1242 (2000); Tolton v. American Biodyne, Inc., 48 F.3d 937 (6th Cir. 1995); supra note
98 (discussing additional cases).
2000]
53
Jordan: Jordan: Coverage Denials in ERISA Plans:
Published by University of Missouri School of Law Scholarship Repository, 2000
MISSOURILA WREVIEW
Fortunately, there is some evidence that lower courts are beginning to
recognize the prominence of the "quality" prong of the Dukes decision in
assessing the preemption issue.2" In the long-awaited case ofPappas v. Asbel,20'
the Supreme Court of Pennsylvania focused on the fact that the state tort claim
against an HMO constituted a regulation of the quality of health care. 2 Pappas
involved an action arising from an HMO's allegedly negligent delay in
authorizing the transfer of the plaintiff to a university hospital with greater
capabilities and resources to treat his medical condition.2"a Relying on the
trilogy of Supreme Court cases, the Pennsylvania Supreme Court held that the
tort claim was not preempted. The court focused on the fact that Travelers
cautioned that Congress did not intend to displace general health care regulation
(historically a matter of local concern)2 4 and especially state laws governing the
provision of "safe medical care."205 The court found that ERISA did not preempt
the tort claim because "[c]laims that an HMO was negligent when it provided
contractually-guaranteed medical benefits in such a dilatory fashion that the
200. There is also evidence that litigants are focusing on the "quality" aspect of the
Dukes test. In the Corporate Health case, the State of Texas also focused on "quality"
in arguing against preemption of the Texas liability provision. See Corporate Health Ins.
Inc. v. Texas Dep't of Ins., 12 F. Supp. 2d 597, 603 (S.D. Tex. 1998). As noted, the
Texas law allows individuals to sue an HMO or other managed care entity for damages
proximately caused by the entity's failure to exercise ordinary care when making a health
care treatment decision. The State of Texas argued that "Senate Bill 386 regulates the
quality of care provided by HMO[s] operating in Texas.... The plain meaning of the
statute shows that the purpose of [the bill] is to prevent plans from escaping liability for
the medical decisions they 'make,' 'control' or 'influence.'" Id.; see supra notes 99-101
and accompanying text (discussing in more detail the Corporate Health decision and the
challenged liability provision).
201. Pappas v. Asbel, 724 A.2d 889 (Pa. 1998). Those interested in ERISA
preemption issues anxiously awaited the Pappas decision because it was one of the first
cases involving the issue of ERISA preemption of a negligence claim against an HMO
to be decided by a state's highest court in the post-Travelers era.
202. Id. at 893. Pappas initially brought suit against his primary care physician and
Haverford Hospital, the hospital which attempted to transfer Pappas. The original
defendants implead the HMO. The Pennsylvania Supreme Court addressed the issue of
ERISA preemption of the tort claim against the HMO. Pappas did not involve an
HMO's "medical necessity" determination; rather, the denial at issue was due to the
HMO's limited provider network and its failure to timely authorize treatment at a non-
participating hospital.
203. Id. at 890. Pappas was diagnosed as suffering from an epidural abscess which
was pressing on Pappas's spinal column. Although not entirely clear from the facts in
the case, Pappas's transfer to a more capable hospital was delayed at least three hours.
Pappas now suffers from permanent quadriplegia resulting from compression of his spine
by the abscess. Id.
204. Id. at 892 (quoting New York State Conference of Blue Cross & Blue Shield
Plans v. Travelers, 514 U.S. 645, 661 (1995)).
205. Id. at 893.
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patient was injured indisputably are intertwined with the provision of safe
medical care."2" Thus, with focus on the fact that the claim constituted a state
regulation of the quality of medical care, it became irrelevant that the claim also
could have been characterized as a challenge to the HMO's UR or pre-
certification process or the IBMO's transfer authorization denial.
As explained in Part 1-(C), a similar analysis was used by the federal
district court in Moscovitch v. Danbury Hospital20 7 In finding that ERISA did
not preempt the claims against the managed care plan, PHS, the court focused
on the fact that the claims challenged the appropriateness of the medical and
psychiatric decisions of PHS. The court noted: "[The claim] does not assert that
PHS was making wrong decisions about whether certain care would be covered
by its plan, but instead challenges the decision made by PHS with respect to the
quality and appropriate level of care and treatment for the decedent." 0"
Although the claim at issue clearly also could have been characterized as arising
from the denial of further coverage for inpatient hospital care, the court decided
that the fact that the claim challenged a medical care decision pulled it outside
the reach of ERISA preemption.2°
In each of these cases, though, the courts suggested that their analyses were.
consistent with Dukes.21 Thus, even these courts have not expressly shifted to
206. Id.
207. 25 F. Supp. 2d 74, 80-83 (D. Conn. 1998). In Moscovitch, state law claims
were brought against Physician Health Services ("PHS"), the entity which administered
the group medical plan covering the plaintiff's son. PHS first authorized admission for
the plaintiff's son to Danbury Hospital after two suicide attempts; but seven days later
terminated the inpatient coverage and required the child to be transferred to Vitam
Center, an allegedly inappropriate facility because Vitam was only prepared to treat
adolescents with substance abuse problems. Claims also were brought against Danbury
Hospital and Vitam Center, Inc. The plaintiff's son committed suicide on the day of the
transfer. The plaintiff's complaint included direct and vicarious tort claims against PHS.
The claims against PHS in the plaintiff's original complaint were grounded in state
statutory provisions. The plaintiff amended the complaint to include, against PHS, only
state common law tort theories grounded in direct and vicarious liability.
208. Id. at 80. The court pointed to allegations that PHS failed to properly
diagnose and assess the decedent's psychiatric condition, failed to properly monitor, care,
and treat him, and failed to properly oversee his treatment. Id.
209. Id. at 82; see also In re U.S. Healthcare, Inc., 193 F.3d 151 (3d Cir. 1999);
Tieman v. U.S. Healthcare, Inc., No. CIV. 99-5885, 2000 WL 62304, at *1 (E.D. Pa.
Jan. 11, 2000). In both cases, the courts found that because the plaintiff's complaints
challenged the quality of a medical determination their claims were protected from
ERISA preemption. However, neither case clearly involved an allegation that the harm
arose from a benefit determination.
210. The concurring opinion in Pappas attempted to expressly explain that the
outcome was consistent Dukes. The concurring judge did explain that the HMO's refusal
to transfer "constituted, in effect, an individual medical decision or judgment as opposed
to a decision affecting the administration of an employee benefit plan," and thus
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a quality test. Nonetheless, the cases reflect the subtle shifting that is the product
of case law development. The quality test is emerging because a focus on
whether the state law constitutes a regulation of the quality of health care ensures
a preemption result more in line with recent Supreme Court signals regarding
congressional intent.
(ii) Application to Coverage Denials
If the quantity-quality test of Dukes gives way to a simple quality test, the
determinative issue in assessing whether a state common law action is
inconsistent with § 502(a)(1)(B) would be whether the state law action
challenges the quality of benefits due under the plan (or, stated more broadly,
whether the state law action challenges the quality of medical decision making).
The fact that the action arises in the context of a benefit determination should not
impact the-analysis. Using a quality standard, some state common law actions
arising from coverage denials likely would still be found inconsistent with
§ 502(a)(1)(B). But some would not.
An action arising from a coverage denial that did not involve an exercise of
medical judgment, for example, cannot readily be characterized as a regulation
of the quality of health care. The essence of such a claim is that benefits were
withheld for some more purely contractual reason. Thus, the claim can be more
readily characterized as a challenge to the quantity of "benefits due." When a
claim does not challenge quality, the fact that it does involve quantity is
determinative; and this is true even if a plaintiff is seeking remedies other than
the benefits, such as damages for emotional distress or punitive damages arising
from a breach of contract. A claim challenging a coverage denial that did not
involve medical decision making is more analogous to the claims in Pilot Life
and would be found inconsistent with § 502(a)(1)(B) and preempted.
In contrast, a Corcoran-type claim is not inconsistent with § 502(a)(1)(B)
under a test based on the quality prong of the Dukes analysis. Although the
Corcorans' claim arose from a denial of benefits, the suit in Corcoran was
essentially a malpractice claim against the UR entity.21 A judgment for a
plaintiff in a suit challenging a negligent medical necessity determination by a
utilization reviewer would impose, on the entity making the UR decision, a duty
to use reasonable care in exercising medical judgment. Thus, the suit would
represent a challenge to the quality of health care and would not be preempted
due to § 502(a)(1)(B). Under a simple quality test, then, the courthouse door
constituted a challenge to the quality of benefits received. Pappas v. Asbel, 724 A.2d
889, 894 (Pa. 1998) (Nigro, J., concurring). But the concurring judge did not mention
that the claim also could have been characterized as a denial of benefits claim. Similarly,
the court in Moscovitch expressly explained that its conclusion was consistent with
Dukes, but failed to address that the claim also could have been characterized as a denial
of benefits claim. Moscovitch, 25 F. Supp. 2d at 80-81.
211. See supra notes 77-85 and accompanying text.
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should be open to at least some suits against managed care plans arising out of
a coverage denial.
2. Suits to Enforce Rights Under the Terms of the Plan
a. The Dukes and Rice Analyses
In addition to a suit to recover benefits due, § 502(a)(1)(B) authorizes a suit
to "enforce rights" under the ERISA plan. The courts in Dukes and Rice both
addressed the question of whether a state law tort claim against a managed care
plan was inconsistent with this part of § 502(a)(1)(B). The Third Circuit in
Dukes interpreted this language in § 502(a)(1)(B) very narrowly. Dukes held
that a state tort claim could be characterized as a § 502(a)(1)(B) suit only if the
claim would enforce a contract right other than the right to benefits; and, indeed,
something to which plan participants would not otherwise be entitled.2 2 The
court readily concluded that neither a vicarious liability claim based on negligent
provision of care nor a direct negligence claim alleging negligent selection and
retention of providers would fall within the scope of § 502(a)(1)(B) because
"patients enjoy the right to be free from medical malpractice regardless of
whether or not their medical care is provided through an ERISA plan.'2 13 Thus,
the key inquiry under Dukes is whether permitting the state tort claim to proceed
would result in the enforcement of a right that is distinct from a right to benefits
and accorded to the plaintiff only by the contractual terms of the plan.
The court in Rice took a broader view. Because evidence of the agency
relationship required for vicarious liability would be found in plan documents,
the Rice court decided that it was necessary to conduct a more complex analysis
of whether this rendered the plaintiff's vicarious liability claim a suit to enforce
his rights under the plan.214 The court elected to follow the rule developed for
determining the preemptive scope of Section 301 of the Labor Management
Relations Act ("LMRA"). 2 5 Under that approach, the key inquiry is whether
212. Dukes v U.S. Healthcare, Inc., 57 F.2d 350, 358 (3d Cir.), cert. denied, 516
U.S. 1009 (1995).
213. Id. It is not absolutely clear that the court was referring to both the direct and
vicarious claims since a claim for negligent credentialing generally is not considered a
"malpractice" claim. But it is a reasonable conclusion since throughout the opinion the
court essentially treated the two claims as one.
214. Rice v. Panchal, 65 F.3d 637, 642 (7th Cir. 1995).
215. The Labor Management Relations Act ("LMRA"), codified in scattered
sections of 29 U.S.C., was enacted as an amendment to the National Labor Relations Act
('NLRA"). Although the NLRA was the first federal law recognizing the right of
workers to form a union, the LMRA was intended to limit the power of organized labor.
The Supreme Court has often analogized ERISA's preemption with § 301 preemption.
Section 301 of the LMRA recognizes collective bargaining agreements as enforceable
contracts and grants federal district courts original jurisdiction over suits involving
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resolution of the state law claim will require an interpretation of the ERISA
plan.216
The issue raised by the plaintiff's claim in Rice was whether the physician's
status as a "participating provider" rendered the defendant insurer/administrator
liable for the physician's malpractice under the law of respondeat superior.
Under state law, resolution of the case would have hinged on issues such as
whether the plaintiff justifiably relied on the physician, whether the physician
was authorized to act, and whether the plaintiff was put on notice of the lack of
the physician's authority.27 The court explained that, due to the factual nature
of the inquiry, Rice's claim would not require interpretation of the ERISA plan;
further, the fact that the plan might serve as some evidence of the agency
relationship did not meet the Section 301 standard.2"' Thus, the court found that
the vicarious liability claim was not a suit to enforce rights under the terms of the
plan.219
violations of those agreements. See LMRA § 301, 29 U.S.C. § 185(a) (1994). Because
of the importance of uniform interpretation of § 301 collective bargaining agreements,
courts scrutinize suits brought by a party to a collective bargaining agreement even if the
complaint alleges a state law claim that does not, on its face, allege a breach of a § 301
agreement. A body of case law is devoted to determining whether a state law claim that
does not allege a breach of a § 301 contract is nonetheless properly considered a claim
within the scope of§ 301. See, e.g., Rice, 65 F.3d at 643 (citing Lingle v. Norge Div. of
Magic Chef, Inc., 486 U.S. 399 (1988); Livadas v. Bradshaw, 512 U.S. 107 (1994); Allis-
Chalmers Corp. v. Lueck, 471 U.S. 202 (1985)). The court in Rice held that this § 301
case law should inform the analysis of whether a state law claim that does not allege a
breach of an ERISA plan is nonetheless properly recharacterized as a § 502(a)(1)(B) suit
to enforce rights under the terms of the plan. Thus, the Seventh Circuit believes that the
need for uniform interpretation of ERISA plans is so strong that any state law claim
whose resolution depends on an interpretation of the terms of the ERISA plan (i.e., the
terms of the coverage policy) becomes a federal ERISA claim "to enforce the terms of
the plan." Interestingly, the Dukes and Rice approaches to the question of what claims
can be characterized as claims to enforce the terms of an ERISA plan can be harmonized.
One view of when the § 301 standard is met is whether the state law claim is
"independent"--in that it does not depend on the existence of a collective bargaining
agreement. See Mark L. Adams, Struggling Through the Thicket: Section 301 and the
Washington Supreme Court, 15 BERKELEY J. OF EMP. & LAB. LAw, 106, 106-40 (1994)
(citing Stephanie R. Marcus, Note, The Needfor a New Approach to Federal Preemption
of Union Members 'State Law Claims, 99 YALE L. J., 209, 209-230 (1989-90)). This is
in essence the test articulated by the court in Dukes. However, the case law articulating
the scope of preemption under § 301 of the LMRA is itself the subject of considerable
dispute. Thus, the Seventh Circuit's approach to the ERISA preemption analysis is
bound to muddy the waters considerably more than the Third Circuit's more
straightforward approach.
216. Rice, 65 F.3d at 644.
217. Id. at 645.
218. Id.
219. This is a narrower view than some lower courts had previously taken. See,
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b. Application to Coverage Denials
The analyses used in Dukes and Rice similarly show that some state
common law actions arising from coverage denials may be found inconsistent
with § 502(a)(1)(B), but that some would not. First, a state common law action
challenging a denial of coverage based on conduct that did not involve an
exercise of medical judgment might be found to constitute a suit "to enforce
rights" due under the terms of the plan. The essence of such a claim is that
benefits were withheld for a reason more contractual in nature. Thus, the claim
would not satisfy the test articulated by the Dukes court because it would be
enforcing the right to benefits due under the plan terms-not a contract right
other than the right to benefits. However, because resolution of the claim would
require the interpretation of the plan, the claim would seem to satisfy the Rice
test. If so, the claim could be found preempted due to an inconsistency with
§ 502(a)(1)(B).
A state law claim arising from a coverage denial involving an exercise of
medical judgment, however, is not a suit "to enforce rights" under an ERISA
plan under either test. A policyholder's right to be free from negligent medical
decision making is independent from the ERISA plan. Thus, such a claim
generally would not enforce a right conferred by the contract and, under the
Dukes approach, the claim would not fall within the scope of § 502(a)(1)(B).
Similarly, a state law claim challenging conduct involving an exercise of medical
judgment generally would not constitute a suit "to enforce rights" under the
approach established in Rice. However, a fuller analysis of the outcome under
the approach used in Rice is necessary.
Under Rice, whether a state law tort suit constitutes a suit to enforce rights
under the terms of the plan depends on whether resolution of the state law suit
will require an interpretation of the ERISA plan. When the suit involves health
benefits, the relevant plan document is the policy setting forth health coverage.
Some policies simply cover certain medical services, as long as a utilization
reviewer agrees that the treating physician's recommendation is for a covered
service that is "medically necessary" or "reasonable and necessary." In that
case, the issue raised by a claim challenging an allegedly negligent UR decision
is whether the review failed to conform to accepted medical standards.
Resolving that issue would not-and should not-require interpretation of the
coverage policy.
Other policies, however, may go further and have specialized definitions of
what constitutes "medically necessary" or "reasonable and necessary." In such
a case, it is less clear whether resolution of the state law suit will require an
interpretation of the ERISA plan. As explained in Part II(B), some tort actions
e.g., Nealy v. U.S. Healthcare HMO, 844 F. Supp. 966, 972 (S.D.N.Y. 1994) (holding
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arising in connection with a denial of coverage under a more detailed definition
of medical necessity could be characterized as actions challenging conduct that
involved contractual interpretation or application but not an exercise of medical
judgment. For example, what if the policy stated that, to be medically necessary,
a treatment must be approved for reimbursement by the Health Care Financing
Agency, and a denial of coverage was based on a finding that the treatment was
not so approved? In such a case, resolution of the plaintiff's claim that the
coverage denial was wrongful and that the managed care plan should be
accountable for the resulting harm may well involve an interpretation of the
health coverage policy. Thus, under the Rice approach, the state law claim
would be inconsistent with § 502(a)(1)(B) and would be preempted. Other than
that type of situation, however, a state tort action arising in connection with a
denial of coverage involving medical decision making generally would not be
found to be inconsistent with § 502(a)(1)(B).
C. Despite a Narrower View of Preemption, Some Claims Arising
from Coverage Decisions Would Still Be Preempted-and a Federal
Legislative Solution Is Thus Preferable
This necessarily lengthy and complex analysis shows that, even under the
emerging, narrower view of preemption, some state claims against managed care
plans arising from a coverage denial would remain preempted. The analysis
strongly supports the argument that, under the emerging approach, courts should
find that Congress did not intend for ERISA to preempt those claims arising
from coverage denials that involve medical decision making and that would
constitute state regulation of the quality of health care. Because recent Supreme
Court precedent has undermined the rationale used by the Fifth Circuit in
Corcoran, such a claim should not be found to have a sufficient effect on ERISA
plans to warrant preemption under § 514(a) of ERISA. Partly because of that,
such a claim also should not be found to be preempted for inconsistency with
§ 502(a)(1)(B). Additionally, that view is supported by tests articulated by
recent circuit courts of appeals decisions for use in determining whether such a
claim falls within the scope of§ 502(a)(1)(B). In contrast, however, state claims
arising from a coverage denial that did not involve medical decision making
stand on different footing. Claims that do not challenge medical decision
making cannot be characterized as state regulation of the quality of health care.
Thus, under both the Supreme Court trilogy and the appellate court tests, this
type of suit may still be found to be preempted.
The issue becomes, of course, what does this mean in terms of the debate
over a federal legislative solution to the preemption problem. That is, is a
federal amendment to ERISA necessary if the courthouse door is being opened
for at least some claims against managed care plans? The answer to that
question depends on whether the permissible claims would provide sufficient
regulation of coverage denials by managed care plans.
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Under the emerging judicial view of preemption, permissible claims would
be those that regulate the quality of medical necessity determinations made by
managed care plans. That is, claims that would hold managed care plans
accountable for medical decision making and that are akin to the types of suits
used to hold health care professionals liable for their negligence, such as claims
for managed care plan "medical malpractice liability" or claims holding plans
vicariously liable for medical decisions made by their "medical directors. '22
Because of ERISA preemption, few cases exist that directly support extension
of medical malpractice liability to managed care plans.22' Significantly,
however, sufficient case law exists to warrant the assumption that, if the ERISA
preemption barrier is removed, courts will fill the void.222
220. In Moscovitch, the plaintiff asserted a medical malpractice claim directly
against the managed care plan. See supra notes 107-11 and accompanying text. In other
cases, plaintiffs have sought to hold the plan vicariously liable for medical decision
making by plan administrator or other agent. See, e.g., Hull v. Fallon, 188 F.3d 939, 941
(8th Cir. 1999), cert. denied, 120 S. Ct. 1242 (2000); Jass v. Prudential Health Care Plan,
Inc., 88 F.3d 1482, 1484 (7th Cir. 1996); Crum v. Health Alliance-Midwest, Inc., 47 F.
Supp. 2d 1013, 1016 (C.D. Ill. 1999).
221. Medical malpractice claims arising from allegedly negligent determinations
of medical necessity involve "coverage denials" and, thus, historically have been viewed
as preempted. See supra notes 94-106.
222. The foundation for such a claim was laid in two landmark cases out of
California. See Wickline v. California, 228 Cal. Rptr. 661, 670 (Ct. App. 1986); Wilson
v. Blue Cross of Southern California, 271 Cal. Rptr. 876, 886 (Ct. App. 1986). Wickline
recognized several important principles: (1) that an erroneous prospective or concurrent
UR decision likely results in the withholding of necessary care and potential injury to
the patient; (2) that patients injured when care is not provided should recover from all
those responsible for the wrongful deprivation of care; (3) that a UR decision often
involves an exercise of medical judgment; and (4) that payers can be held legally
accountable when medically inappropriate decisions result from defects in the design or
implementation of cost containment mechanisms. Wilson confirmed the view that the
imposition of tort liability on a private managed care plan is appropriate when warranted
by the facts.
More recently, two state supreme courts have implicitly recognized the applicability
of a malpractice type of claim against a managed care plan. See McEvoy v. Group
Health Coop., 570 N.W.2d 397,402-03 (Wis. 1997); Long v. Great West Life & Annuity
Ins. Co., 957 P.2d 823, 832 (Wyo. 1998). In McEvoy, the court held that the theory of
tortios breach of contract could apply to HMOs. Specifically, the court held that, when
the UR decision is a nonmedical, coverage-related decision, the "HMO should be held
to the same level of responsibility for its actions as a traditional insurance company."
McEvoy, 570 N.W.2d at 404. Logically, the McEvoy opinion also stands for the converse
proposition; namely, that, the more closely the decision at issue resembles an exercise
of medical judgment made by a health care provider, the more appropriate the tort of
malpractice becomes; and the HMO should be held accountable to the same extent as
health care providers, through the tort of medical malpractice.
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Thus, under the emerging view of preemption, ERISA plan participants and
beneficiaries could bring tort suits that would create an incentive to use
reasonable care in making medical decisions that are part and parcel of benefit
determinations. . Lack of accountability for negligent medical necessity
determinations is viewed by many as the most egregious aspect of the
preemption problem.223 Accordingly, a significant component of consumer
concerns could be addressed without a federal legislative provision amending the
scope of ERISA preemption.
Yet, many likely believe that other managed care practices need to be
addressed as well. For example, what if a managed care plan denies a claim for
benefits for the stated reason that the enrollee did not have a referral from the
enrollee's primary care physician, but the enrollee really did have the referral?
Or what if a claim for benefits is denied because the enrollee went to her
physician's office twice in one calendar year as purportedly permitted by the
policy, but the visits were not exactly six months apart as the managed care plan
interpreted the policy to require? Further, what if the managed care plan denied
these claims knowing that, if appealed, they would be paid, but hoping that they
would not be appealed so that the plan would never have to pay the claims?
Denials such as these would be based on contract language and not on
determinations of medical necessity.
Thus, rather than a "medical malpractice" type of claim, a suit challenging
denials based on managed care practices other than medical decision making
would likely take the form of a suit for bad faith or tortious breach of contract.' 4
Courts developed the bad faith breach of contract claim to encourage fair
treatment of insureds and to penalize unfair and corrupt insurance practices.225
223. See, e.g., David Mechanic, Managed Care as a Target ofDistrust, 277 JAMA
1810 (1997). See also National Coalition on Health Care, Survey, A Reality Check: The
Public's Changing View's of Our Health Care System (1996), available in
<http://www.nchc.org/emerg/exec0498.html>. One commentator states:
Patients and physicians are concerned--quite justifiably-about the effect
that a system riven by economics will have on quality of care and professional
independence. Patients fear that care managers will pay insufficient attention
to the clinical consequences of their actions and will engage in de facto
rationing of expensive services. Physicians fear they will be caught between
a rock and a hard place, beset on one side by arbitrary contracting policies and
administrative requirements and on the other by legal responsibility for sub-
optimal clinical outcomes.
Sage, supra note 27, at 162.
224. Most states have recognized that insurers are subject to a duty to act in good
faith and to deal fairly with their insureds. An insurer's breach gives rise to a cause of
action for tortious breach of contract. The cause of action is intended to compensate the
insured for injury caused by the insurer's wrongful conduct, not for benefits covered by
the policy. See generally John H. Bauman, Emotional Distress Damages and the Tort
of Insurance Bad Faith, 46 DRAKE L. Rnv. 717 (1998).
225. See McEvoy, 570 N.W.2d at 402 (citing cases). The tort of bad faith is a
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Although traditionally applied to insurance companies, courts have extended the
tort to managed care plans.226 Indeed, both Karen Johnson and Teresa Goodrich
pursued and successfully obtained compensatory and punitive damages through
bad faith breach of contract claims against their managed care plans.2" Because
a bad faith breach of contract claim regulates unfair insurance practices or
analogous managed care plan activities, the claim does not constitute state
regulation of health care.
Suits challenging managed care plan practices other than medical decision
making therefore would not represent state regulation of the quality of care and
thus would continue to be found preempted.228 ERISA plan participants could
bring a suit under § 502(a)(1)(B), but would be barred from any extracontractual
damages. Thus, a claimant would be limited to recovery of benefits due (e.g.,
payment of the claim) notwithstanding any bad faith in the coverage denial.229
Accordingly, many ERISA plan participants and beneficiaries would likely think
it preferable to have a federal legislative solution to the preemption problem that
would not only permit suits against managed care plans for malpractice-type
claims, but would also permit suits involving claims for bad faith breach of
contract in order to provide an incentive for managed care plans to act fairly. If
a federal legislative solution is preferable in order to satisfactorily emasculate the
shield of ERISA preemption, the issue becomes whether the Norwood-Dingell
bill represents a sound legislative solution.
VI. ASSESSMENT OF THE SOLUTION PROPOSED IN THE
NORWOOD-DNGELL BILL
As explained in Part IV of this Article, the Norwood-Dingell bill 230 would
broadly open the door to state common law claims against managed care plans.
hybrid claim, based on both contract and tort principles. The theory recognizes that "bad
faith by one party to a contract toward another is a tort separate and apart from a breach
of contract and that separate damages may be recovered for the tort." Id.
226. Id.
227. See supra notes 1-3 & 41-47 and accompanying text.
228. See, e.g., Buters v. Royal Maccabees Life Ins. Co., 174 F.3d 1207, 1213 (1 1th
Cir. 1999) (holding that claims asserting breach of contract and bad faith refusal to pay
are within the scope of§ 502(a)(1)(B) of ERISA). Further, although a bad faith breach
of contract claim arguably represents "state regulation of insurance," such a claim is not
likely to be found to be exempt from preemption under ERISA's saving clause. See Pilot
Life Ins. Co. v. Dedeaux, 481 U.S. 41, 50-52 (1985) (holding that a state common action
for bad faith breach of contract, although developed in the context of insurance contracts,
was not a state liw "regulating insurance" and thus saved from preemption because the
cause of action evolved from general principles of tort and contract law).
229. See supra note 181 and accompanying text. But see Jordan, supra note 57,
at 273.
230. H.R. 2723, 106th Cong. (1999).
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The Norwood-Dingell bill amends § 514 of ERISA by adding a subsection
which states that:
[N]othing in this title shall be construed to invalidate, impair, or
supersede any cause of action by a participant or beneficiary... under
State law to recover damages resulting from personal injury or for
wrongful death against any person-(i) in connection with the
provision of insurance, administrative services, or medical services by
such person to or for a group health plan, or (ii) that arises out of the
arrangement by such person for the provision of such insurance,
administrative services, or medical services by other persons.23" '
The provision does not attempt to delimit in any way the types of state law
claims that are exempt from preemption, or the type of conduct that could give
rise to a claim.u2 An action could arise from any aspect of a managed care
plan's operation that results in personal injury or wrongful death. The provision,
therefore, would satisfy consumer concerns about managed care plan
accountability by allowing both malpractice-types of claims and claims for bad
faith breach of contract. But, whether the Norwood-Dingell bill represents a
sound legislative solution depends on whether the provision goes too far in
opening the door to managed care plan liability.
Notably, the Norwood-Dingell bill does contain some significant limitations
which seem to address many of the concerns reflected in the alternate bills that
surfaced in the House. The publicized limitations in the bills offered as
alternatives to the Norwood-Dingell bill involved only "who" could be held
accountable (e.g., the person making the sole final decision), the degree of harm
necessary to support a claim (e.g., upon a showing of substantial harm), and
"how much" could be recovered (e.g., only up to designated dollars caps on
noneconomic and punitive damages).2 3 The Norwood-Dingell bill, if examined
closely, contains similar limitations.
First, the Norwood-Dingell bill has a restriction regarding who would be a
proper defendant to a claim brought by a plan participant or beneficiary.
Although the Norwood-Dingell provisions would allow a state suit against any
managed care plan, regardless of its organizational form, the bill would not
authorize any claim (including a claim for indemnity) against "an employer or
other plan sponsor maintaining the group health plan (or against an employee of
231. See H.R. 2723 § 302(a) (amending § 514 of ERISA by adding
§ 514(e)(1)(A)(i)-(ii)).
232. Further, the bill would not require ERISA plan participants and beneficiaries
to exhaust the plan's administrative process where the injury or death occurred before
completion of the process. H.R. 2723 § 302(a) (amending § 514 of ERISA by adding
§ 514(e)(3)).
233. See supra notes 121-24 and accompanying text.
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such employer)." 4 This seems like an appropriate balance given consumer
concerns regarding managed care plans generally. Protecting employers or
unions from lawsuits will allay concerns that the provision may cause employers
to discontinue health coverage. On the other hand, the alternative of requiring
an ERISA plan participant or beneficiary to identify the person making the "sole
final decision" seems an unnecessary complication.
Second, the Norwood-Dingell bill also has a limitation on the degree of
harm necessary to support a claim. The bill encompasses only claims resulting
in wrongful death and personal injury. 5 Personal injury is defined as "personal
injury," although it includes "an injury arising out of the treatment (or failure to
treat) a mental illness or disease 536 Again, this seems to strike an appropriate
balance. The limitation precludes lawsuits based on state claims when enrollees
are simply disgruntled by the strategies or coverage decisions of a managed care
plan, even if their disgruntlement rises to the level of emotional distress. Yet, the
bill permits recovery when harm is tangible and does not complicate the action
with an ambiguous requirement of "substantial harm."
Third, the bill has a restriction on the availability of punitive damages.
However, the Norwood-Dingell limitation on punitive damages would not
provide as much protection from punitive damages to managed care plans as
some of its alternatives. The Norwood-Dingell bill provides that the plan would
not be liable for punitive damages if the claim relates to an "externally
appealable decision"; the external appeal was initiated in a timely manner and
completed; and the plan complied with the determination resulting from the
external appeal." As noted, an "externally appealable decision" under the bill
is a coverage denial arising from conduct involving an exercise of medical
judgment." Thus, the Norwood-Dingell bill limitation would apply only to
234. However, this exemption from liability is not available if the action is based
on "the employer's or other plan sponsor's (or employee's) exercise of discretionary
authority to make a decision on a claim for benefits covered under the plan or health
insurance coverage" and if that exercise of authority results in personal injury or
wrongful death. H.R. 2723 § 302 (amending § 514 of ERISA by adding
§ 514(e)(2)(B)(i)-(ii)). Further, the bill defines the phrase "an exercise of authority" to
protect certain types of decisions: a decision to include or exclude from the plan any
specific benefit, a decision to provide extracontractual benefits, and a decision to refrain
from making any decision about the provision of a benefit while internal or external
review is being conducted. H.R. 2723 § 302(A) (amending § 514 of ERISA by adding
§ 514(e)(2)(C)(i)-(iii)).
235. H.R. 2723 § 302(a) (amending § 514 of ERISA by adding § 514(e)(1)(A)).
236. Although physical injury "includes an injury arising out of the treatment (or
failure to treat) a mental illness or disease." H.R.2723 § 302(a) (amending § 514 by
adding § 514(e)(1)(C)). Where no physical injury has occurred, plan enrollees will still
have available a cause of action under ERISA for recovery of "benefits due."
237. H.R. 2723 § 302(a) (amending § 514 of ERISA by adding § 514(e)(1)(B)(i)-
(iv)).
238. The term is defined as:
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claims arising from coverage denials involving an exercise of medical decision
making 9 and, therefore, it would not apply to suits based on the tort of bad faith
breach of contract. As the Johnson and Goodrich cases show, large punitive
damages verdicts can result in cases based on bad faith claims.24 Thus, the
provision reflects a compromise: The potential for liability would address
consumer concerns about the accountability of managed care plans, and the
restriction on punitive damages if an external appeals process is properly used
would protect both consumers (as it is likely to encourage proper use of an
external appeals process) and managed care plans.
The question becomes whether the Norwood-Dingell restriction on punitive
damages is sufficient. The alternate bills would have gone further. One bill
would have capped punitive damages at the greater of $250,000 or twice the
economic damages.241' Another would have banned punitive damages altogether
if the plan's denial was upheld by external reviewers.242 On the one hand, the
more limited restriction in the Norwood-Dingell bill is arguably more
appropriate than the broader ban on punitive damages offered in the alternative
bills. To recover punitive damages in bad faith claims, plaintiffs generally must
show that the defendant acted maliciously or with reckless or gross disregard of
the plaintiff.243 If a plaintiff has strong evidence of such conduct by the managed
care plan in relation to a coverage denial, should the managed care plan be
protected to the extent that it would be with a broader ban on punitives?
A denial of claim for benefits... (i) that is based in whole or in part on a
decision that the item or service is not medically necessary or appropriate or
is investigational or experimental; or (ii) in which the decision as to whether
a benefit is covered involves a medical judgment.
H.R. 2723 § 103(a)(2).
239. The House Bill provides that the plan would not be liable for punitive
damages if the claim relates to an "externally appealable decision"; the external appeal
was initiated in a timely manner and completed; and the plan complied with the
determination resulting from the external appeal. See H.R. 2723 § 302(a) (amending
§ 514 of ERISA by adding § 514(e)(1)(B)(i)-(iv)). An "externally appealable decision!'
would be a coverage denial arising from conduct involving an exercise of medical
judgment.
240. See also Bauman, supra note 224, at 749-54 (exploring the appropriateness
of allowing recovery of damages for emotional distress in bad faith breach of contract
claims).
241. See Norwood-Dingell Managed Care Bill, supra note 121, at d2 (describing
Coburn-Shadegg bill).
242. Id. (describing the Houghton amendment).
243. See, e.g., Anderson v. Continental Ins. Co., 271 N.W.2d 368, 376-77 (Wis.
1978) (explaining that a plaintiff must show the "absence of a reasonable basis for
denying benefits of the policy" plus the insurance company's "knowledge or reckless
disregard of the lack of a reasonable basis for denying the claim"). Professor Bauman
has noted that judicial formulations such as this one require the plaintiff to show that the
tort was an intentional one. See Bauman, supra note 224, at 741-42.
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Arguably no: Because without the possibility of punitive damages, there is no
real incentive to avoid "bad faith" denials in the future.
On the other hand, a broader limitation on punitive damages in all cases
against managed care plans, including bad faith breach of contract claims, may
lessen the financial consequences of allowing suits arising out of coverage
denials and thereby help ensure that any federal legislative solution will not
result in employers discontinuing the provision of health benefits. The
legitimacy of that concern is debatable;2' and indeed, perhaps it represents a
factor that is truly unquantifiable.245 Nonetheless, if a broader ban on punitive
damages is crucial in order to get a federal solution to the ERISA preemption
problem, supporters of the Norwood-Dingell bill should make the compromise.
The result would still leave ERISA plan participants and beneficiaries in
better position than they are without a federal legislative solution. Without a
federal legislative solution, courts can open their doors only to suits challenging
coverage denials involving an exercise of medical decision making (i.e.,
managed care plan medical malpractice claims). If the Norwood-Dingell bill is
enacted, plan participants and beneficiaries would also be able to challenge other
coverage denials-those not involving an exercise of medical judgment, but
involving some other questionable managed care tactic (e.g., bad faith breach of
contract claims). Even if punitive damages are not allowed, plan participants
and beneficiaries would be able to recover compensatory damages for physical
injuries.246 This is a remedy currently unavailable to ERISA plan participants
and beneficiaries, and is definitely a step in the right direction. Most legislative
solutions involve a balancing of competing interests. Adopting the Norwood-
Dingell provision, with a compromise on the issue of punitive damages, seems
an appropriate balance to strike in this area.
VII. CONCLUSION
Most lower courts have continued to find that ERISA plan participants and
beneficiaries are barred from pursuing any suit against a managed care plan for
injuries sustained as a result of the plan's wrongful denial of benefits. Suits
arising from coverage denials are found to be preempted whether the denial is
based on a more purely contractual reason or on conduct involving the exercise
of medical judgment. This Article concludes that a federal legislative solution
to the preemption problem in cases involving coverage denials is appropriate
244. See supra note 169 and accompanying text.
245. See Rand Study on ERISA Health Plan Liability Yields Mixed Results,
MEALEY'S MANAGED CARE LIABILITY REP., July 28, 1999, at 19 (reporting that a study
by the RAND Institute for Civil Justice found that support for claims on both sides of the
debate is weak "as most of the necessary data for accurate estimates are not available").
246. In addition, in appropriate cases plan participants and beneficiaries may be
able to recover damages for emotional distress in claims based on bad faith breach of
contract. See Bauman, supra note 224, at 752.
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because, although the emerging judicial view of preemption might permit state
law claims challenging coverage decisions based on medical decision making,
state law claims that would provide an incentive for managed care plans to act
fairly would likely remain preempted.
Further, the Article concludes that the liability provisions in the Norwood-
Dingell bill reflect a basically sound solution to the preemption problem. First,
the liability provision in the Norwood-Dingell bill would largely eviscerate the
preemption problem by carving out from the scope of ERISA preemption any
state law causes of action against plans when coverage denials result in personal
injury or wrongful death, including malpractice-types of claims and claims for
bad faith breach of contract. Second, the Norwood-Dingell bill contains
significant limitations on the right to sue which arguably reflect a meaningful
balancing of the interests at stake. The provisions would protect employers and
plan sponsors from liability and restrict suits to cases involving physical injury.
Further, the bill would ban punitive damages in cases involving coverage denials
based on an exercise of medical judgment if the appeals process is properly
accessed and complied with by the managed care plan.
However, punitive damages would be available and unrestricted in other
coverage denial cases, thereby providing fuel for the arguments that the liability
provisions will cause costs to rise and employers to drop health coverage. Thus,
further compromise on the issue of punitive damages may be prudent if
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